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ABSTRACT 
Aim: To investigate the effects of dopaminergic medications on turning while walking in 
older adults with mild to moderate Parkinson’s disease (PD). A further aim was to develop a 
training program targeting balance impairments related to PD, to verify the progression of 
this program and the specific effects on balance and gait, as well as the transfer effects on 
everyday living. 
Methods: This thesis contains an experimental and a clinical part. In the experimental part, 
quantitative motion analysis was used to evaluate pre- and unplanned walking turns. Nineteen 
individuals with PD were tested after overnight withdrawal of dopaminergic medication and 
approximately one hour after taking their usual dose of medication, and were compared with 
17 healthy control subjects. In the clinical part, a training program with highly-challenging 
balance exercise and dual-tasking was developed through workshops and pilot testing. 
Thereafter, training progression of dynamic exercises throughout this program was evaluated 
with accelerometers in two training groups (n = 6 and 4). In a randomized controlled trial, 
100 individuals with PD were randomized, either to a training group that received a 10-week 
highly-challenging balance exercise intervention with dual-tasking or to a control group 
(usual care). The efficacy of this intervention was evaluated before and after the intervention 
which included specific effects; balance, gait with and without performing a concurrent 
cognitive task, and transfer effects which were concerns about falling, level of physical 
activity and activities of daily living. 
Results: Dopaminergic medication had a positive increasing effect on turning distance, 
whereas no effects on body rotation were found. Compared with the healthy control group, 
individuals with PD demonstrated lower turning distance and body rotation, and turned with a 
narrower step width. The objective evaluation of training activity revealed that training 
progression was accomplished in two independent training groups. The randomized 
controlled trial demonstrated significant improvements in balance control and gait 
performance in the training group, compared with the control group. The training group also 
improved their performance of the cognitive task while walking; however, no group 
differences were found for any gait parameters during dual-tasking. Significant differences, in 
favor of the training group, were found for the level of physical activity and activities of daily 
living, while no group difference was found for concerns about falling. 
Conclusions: Compared with the performance of the healthy control group, dopaminergic 
medication does not normalize turning performance. These residual turning impairments 
were accompanied by difficulties alternating step width during turning, which could be 
important to address in the rehabilitation of individuals with PD. Highly-challenging balance 
exercises, including dual-task, for a 10-week period was progressive and improved balance 
and gait performance in older adults with PD, compared with usual care. Positive transfer 
effects on activities of everyday living were also revealed, indicating that appropriate training 
programs could promote physical activity and daily activities in individuals with PD. 
SAMMANFATTNING 
Syfte: Att utvärdera effekterna av sedvanlig Parkinsonmedicinering för gående vändning hos 
äldre personer med mild till måttlig Parkinsons sjukdom (PS); samt utveckla ett 
balansträningsprogram specifikt riktat mot besvären vid PS, att undersöka progressionen av 
detta program, och att studera programmets effekter avseende balans- och gångförmåga, samt 
dess generella effekter avseende aktiviteter i det dagliga livet. 
Metod: Denna avhandling innehåller en experimentell och en klinisk del. I den 
experimentella delen användes kvantitativ rörelseanalys för att studera planerad och 
oplanerad gående vändning. Nitton deltagare med PS testades först efter att ha varit 
omedicinerade i cirka 12 timmar och sedan cirka 1 timma efter intag av ordinarie medicin, 
och jämfördes därefter med 17 friska kontrollpersoner. I den kliniska delen utvecklades först 
ett 10-veckors träningsprogram med utmanande balansövningar och dual-task till följd av 
workshops och en efterföljande pilotstudie. Därefter undersöktes progressionen av dynamiska 
balansövningar under interventionen med accelerometrar i två träningsgrupper (n = 6 
respektive 4). I den randomiserade kontrollerade studien lottades 100 deltagare med PS till en 
träningsgrupp som deltog i ett 10-veckors program med utmanade balansövningar och dual-
task, respektive en kontrollgrupp som erhöll sedvanlig behandling. Utvärdering skedde före 
och efter interventionen avseende specifika effekter; balanskontroll, samt gångförmåga med 
och utan en kognitiv uppgift, respektive generella effekter; oro för att falla, grad av fysisk 
aktivitet och aktiviteter i det dagliga livet. 
Resultat: Gående vändning under inverkan av Parkinsonmedicin resulterade i en positiv 
effekt avseende ökad gångsträcka av vändningen, dock förblev rotation av kroppen 
oförändrad. I jämförelse med den friska kontrollgruppen, påvisades deltagarna med PS lägre 
uppnådd gångsträcka och grad av kroppens rotation, samt smalspårig stegbredd vid vändning. 
Progressionen av träningsprogrammet bekräftades i båda träningsgrupperna. 
Träningsgruppen, i jämförelse med kontrollgruppen, visade signifikanta förbättringar av 
balans- och gångförmåga, samt utförandet av den kognitiva uppgiften under dual-task. 
Däremot förbättrade träningsgruppen inte gångförmågan under dual-task. Deltagande i 
träningen medförde dessutom signifikanta förbättringar avseende fysisk aktivitet och 
aktiviteter i det dagliga livet i jämförelse med kontrollgruppen, oron för att falla påverkades 
dock inte. 
Konklusion: I jämförelse med prestationen i den friska kontrollgruppen, normaliserade inte 
Parkinsonmedicinering förmågan att gå och vända. Dessa kvarstående besvär var förknippade 
med svårigheter att förändra stegbredden under vändning vilket kan vara viktigt att beakta i 
rehabiliteringsprogram för personer med PS. Utmanade balansträning med dual-task övningar 
under 10-veckor visade sig vara progressiv och ledde till förbättrad balanskontroll och 
gångförmåga. Träningen ledde även till positiva effekter för aktiviteter i det dagliga livet, 
vilket indikerar att resultatet av utmanande balansträning kan öka fysisk aktivitet och 
förbättra aktiviteter i det dagliga livet.  
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DEFINITION OF CONCEPTS 
Activity Execution of a task or action by an individual.
1
 
Automatic control Movements controlled without the attention of the 
individual.
2
 
Balance control The act of maintaining postural stability and postural 
orientation.
3
 
Body functions Physiological functions of body systems.
1
 
Fall-related 
psychological issues 
An umbrella term which covers the negative psychological 
issues that could arise from falls or near-fall events, e.g. fear 
of falling, concerns of falling and loss of balance confidence.
4
 
Dopaminergic 
medication 
Pharmacological agents targeting the neurotransmitter 
imbalance within the basal ganglia circuits. 
Dual-task Simultaneous performance of two tasks with different goals, 
in which one could be referred to as the primary and the other 
as the secondary task.
5
  
Exercise A subset of physical activity that is planned, structured and 
repetitive with the objective to improve or maintain physical 
fitness components.
6
 
Executive control  Movements controlled through the attention of the 
individual.
2
  
Executive function An umbrella term referring to a set of cognitive processes 
(e.g. working memory, inhibition, set shifting and fluency) 
that control goal-directed behavior.
7
 
Level of physical 
activity 
The sum of all activities a person does as part of her/his 
regular day. 
Motor learning A set of processes associated with practice or experience, 
leading to relatively permanent changes in movement 
capability.
8
 
Participation Involvement in life situations.
1
 
Physical activity Any bodily movement produced by skeletal muscles that 
result in energy expenditure.
6
 
Progressive overload A principle implying that training needs to provide a 
challenging overload to the physiological system through a 
certain level of intensity and regularity.
9
 
 Figure 1. Schematic description of the interactional components of the ICF model.
1
 
 
  1 
 
Figure 2. The main concepts in this thesis. 
1 INTRODUCTION 
This thesis is part of a larger research project, the BETA-PD (Balance, Elderly, Training and 
Activity in Parkinson’s disease), with the overall goal of developing and establishing 
evidence-based rehabilitation programs for older adults with Parkinson’s disease (PD). This 
thesis is underpinned by three overlapping concepts; balance control, turning while walking 
and activities of everyday living (Figure 2). As balance control forms the foundation of daily 
activities performance, declining balance control in individuals with PD may gradually 
constrain activities of everyday living. In particular, notwithstanding the problems these 
individuals face in daily life, impaired capacity to turn while walking is a common problem 
that, for many, is a trigger to falls. Dopaminergic medication has a dramatic clinical effect on 
the symptoms of PD; however, the effects of medication on balance control remain uncertain. 
Therefore, in order to sustain independency, it is important to develop training interventions 
that target the disease-related balance impairments of PD. 
Within this thesis, the International Classification of Functioning, Disability and Health (ICF) 
is used as a framework to conceptualize, specifically, impairments and activity limitations 
related to balance impairments in individuals with PD. Methodologically, this thesis is 
divided into two parts: an experimental part (Study I) to determine the effects of 
dopaminergic medication on turning impairments, and a clinical part (Study II-IV) to develop 
an exercise program for addressing balance impairments in PD, and to evaluating the 
progression and effects of this program. Combining experimental and clinical studies enables 
the exploration of different treatment effects on the relevant ICF functioning domains of 
disability in PD. 
1.1 PARKINSON’S DISEASE 
Parkinsonism is an umbrella term that includes several medical conditions which partly share 
the same clinical manifestations.
10
 The focus in this thesis is on idiopathic PD, which is the 
most common type of Parkinsonism.  
 2 
Parkinson’s disease, with a prevalence of approximately 1.2 million in Europe11 and 22 000 
in Sweden,
12
 is the second most common neurodegenerative disease. The incidence of PD is 
more common among males,
12,13
 and most people typically receive the diagnosis after the age 
of 60 years.
14
 Given the tendency that people live longer and that the risk of PD increases 
with age,
13
 the number of people with PD is expected to double by 2030.
15
 
1.1.1 Clinical manifestations and disease progression 
The primary pathophysiology of PD is the progressive degeneration of dopamine-producing 
cells in the substantia nigra.
10
 The diagnosis is mainly based on clinical examination, given 
that bradykinesia is present (i.e. slowness of initiation of voluntary movements with 
progressive reduction of speed and amplitude of repetitive actions) and in combination with 
at least one of the following symptoms: rigidity, resting tremor or postural instability.
10,16
 
Importantly, in addition to these motor features, up to 70% of individuals with PD experience 
non-motor symptoms,
17
 such as olfactory dysfunction, sleep disorders, constipation, 
depression and cognitive impairments.
18-20
 Furthermore, PD is a progressive disease with 
gradually increased impairments and activity limitations which is commonly classified 
according to the original Hoehn and Yahr scale (HY, see Table 1).
21
 However, it is estimated 
that only 4% of individuals with PD reach the late phase of the disease (i.e. HY 5), and PD is 
commonly not the cause of death.
22
 
 
Table 1. Hoehn and Yahr scale 
1: Unilateral involvement only usually with minimal or no functional disability 
2: Bilateral or midline involvement without impairment of balance 
3: Bilateral disease: mild to moderate disability with impaired postural reflexes; physically 
independent 
4: Severely disabling disease; still able to walk or stand unassisted 
5: Confinement to bed or wheelchair unless aided 
 
1.1.2 Pharmacological treatment 
All treatment for PD is symptomatic and aims to optimize activities, participation and quality 
of life.
23
 The first-choice therapy for PD is pharmacological treatment in that dopaminergic 
medication targets the neurotransmitter imbalance within the basal ganglia circuits. The most 
common dopaminergic agents are the dopamine precursor levodopa (L-dopa) which is 
transformed into dopamine in the brain and the dopamine agonists that stimulates the 
dopamine receptor in the striatum.
24
 A common approach is to treat young-onset individuals 
with dopamine agonists and older patients with levodopa.
24,25
 The rationale behind this 
approach is based on the tradeoff between positive effects on motor symptoms and negative 
side effects of these drugs.
24
 Whilst levodopa causes dyskinesia in the long-term, which 
might not be relevant for older individuals, the risk of dyskinesia is decreased with dopamine 
agonists owing to more continuous receptor stimulation.
25
 Still, dopamine agonists lead to 
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other side effects such as sleep disorders, orthostatic problems, impulse control disorders and 
hallucinations.
25,26
 Despite the pharmacological advances made, the lack of consensus 
regarding the optimal treatment approach throughout the progression of PD continues to 
persist.
26,27
 Importantly, despite optimal medical management, individuals with PD still 
experience activity limitations, falls and fall-related injuries.
28
 
1.2 BALANCE CONTROL 
1.2.1 Definitions 
Balance control (or postural control) is defined as the act of maintaining postural stability and 
postural orientation. Postural stability is the ability to control ones center of body mass 
(CoM) relative to the base of support (BoS), whereas postural orientation refers to the ability 
of maintaining an appropriate posture of the body, i.e. the relationships between the body 
segments and the body and environment, respectively.
3,29
 
Within the framework of the ICF, balance control could be conceptualized within the activity 
domain since the preferable output of balance control refers to the safe performance of 
activities. Still, whether or not we succeed in executing activities in a safe manner relies on 
several body functions. Accordingly, managing balance disorders requires a dynamic 
approach where the focus of therapists alternates between body functions and activities.  
Furthermore, if balance control is considered to be a complex skill that is influenced by 
several subdomains as in this thesis, addressing a single activity or body function will most 
likely not be able to sufficiently detect or treat the impairment causing instability.
3,30
 Instead, 
one could argue that the multifaceted nature of balance control needs to be considered while 
managing balance disorders. 
1.2.2 Subdomains of balance control 
Balance control is a complex and task-specific skill that relies on the interaction between 
several physiological systems, environmental factors and the nature of the performed task.
3
 
As such, the central nervous system (CNS) has to rely on different control strategies for 
different activities. Figure 3 illustrates a theoretical model by Horak, covering six different 
domains influencing balance control.
3
 Three of these domains describe varying strategies 
used by the CNS to control balance (i.e. movement strategies, orientation in space and control 
of dynamics), while the remaining three (i.e. biomechanical constraints, sensory information 
and cognitive processing) could be considered as body functions within the ICF. 
 4 
 
Figure 3. Subdomains of balance control according to Horak.
3 
1.2.2.1 Movement strategies 
Importantly, there are no static conditions of the human body, and even quiet standing 
requires fine-tuned adjustments to maintain balance.
31
 In more challenging situations, the 
CNS uses either reactive or proactive responses. First of all, in the case of unexpected 
perturbations, such as after a slip or trip, reactive responses (ankle, hip or step strategy) are 
used to control CoM.
31
 But also voluntary movements have a destabilizing impact on the 
body due to changes in body configuration (i.e. displacement of COM).
31
 Anticipatory 
postural adjustments (APA), or feed-forward control, is a strategy used to predict and 
stabilize CoM disturbances by performing small, unconscious movements before and during 
voluntary movements.
29
 
1.2.2.2 Orientation in space 
Another important control strategy is the ability to control the orientation in space, i.e. the 
ability to orient the body in respect to gravity. For most activities, vertical alignment of the 
body with respect to the support surface serves as an internal reference for the CNS. The 
sensitivity of this system is remarkable in that, healthy individuals can detect and adapt to a 
changing support surface of less than one degree without visual guidance.
32
 
1.2.2.3 Control of dynamics 
Control of dynamics incorporates the complex control of moving CoM during dynamical and 
changeable conditions (e.g. walking). Contrasting to quiet stance, dynamic tasks require the 
CNS to control CoM at the boundaries or outside the boundaries of BoS.
33
 Inevitably, this 
threatens the lateral stability of the body, which requires precise regulation of step width and 
trunk control for sustained balance control.
34
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1.2.2.4 Biomechanical constraints 
Numerous biomechanical constraints, such as size and quality of the base of support, postural 
alignment in the sagittal and frontal plane, muscular weakness and joint range of motion, 
affect balance control.
3,35,36
 Altogether, these factors influence the ability of the body to 
control postural perturbations using the control strategies described earlier. 
1.2.2.5 Sensory information 
For precise control of our movements and posture, sensory information from somatosensory, 
visual and vestibular systems needs to be integrated and transformed into one single reference 
frame by the CNS.
37
 It has been estimated that healthy individuals mainly rely on information 
from the somatosensory system (70%), followed by vestibular (20%) and visual information 
(10%) for stability while standing on a firm surface in a light environment.
32
 However, if the 
sensory environment changes, the CNS re-weight the dependency on the different sensory 
systems
37
 which is important for the ability to adapt to different sensory environments (e.g. 
changing support surface or lights). 
1.2.2.6 Cognitive processing 
There is a growing body of research revealing the interaction between cognition and 
mobility.
2,38,39
 Human movements are believed to be controlled by a balance between 
automaticity, i.e. movements controlled without the attention by the individual, and executive 
control, i.e. movements controlled through the attention by the individual.
40
 Gait incorporates 
both control mechanisms; it has thus been used as a model to study cognitive-motor 
interaction.
2
 Although human walking is modulated by spinal networks,
41
 evidence from 
brain imaging studies has revealed that areas also related to higher cognitive control are 
activated during walking.
42,43
 In healthy individuals, walking is considered to be a highly 
automated skill since minimal use of executive control is needed to coordinate the walking 
pattern.
2
 The automatic control of walking is critical for safe ambulation, since executive 
control may then be allocated to other important aspects of the environment (e.g. an 
approaching obstacle) or to other tasks (e.g. reading items on a shopping list). With disease or 
injury, evidence suggests that the control of walking shifts from being highly automatic to 
executively controlled with the attention on ‘how’ the body is moved.2 Unfortunately, 
executive control of walking has shown to cause an overload to limited cognitive reserves, 
which could potentially lead to unstable walking and increased risk of fall.
39
 
The most widely used behavioral approach to address the impact of cognition on motor 
performance is the assessment of dual-tasking (DT). DT is defined as the simultaneous 
performance of two tasks with different goals, in which one could be referred to as the 
primary and the other as the secondary task.
5
 In the DT paradigm, the primary task is 
performed as a single-task (ST, e.g. walking) as well as a DT (e.g. walking while performing 
a cognitive task). Different theoretical models have been applied to explain DT 
interference,
44-46
 the bottleneck and the capacity-sharing theories as the most commonly 
referred to. The bottleneck theory, postulates that the concurrent performance of two tasks 
 6 
using the same neural network will delay performance of one of the tasks until the network is 
available again.
47
 Thus, according to the bottleneck theory, it is not possible to perform two 
tasks concurrently if they occupy the same neural networks. Conversely, the capacity-sharing 
model suggests that it is possible to perform two tasks simultaneously, however, the amount 
of available capacity is restricted and performance degrades if the total capacity is 
exceeded.
48
 
1.3 BALANCE IMPAIRMENTS IN PARKINSON’S DISEASE 
Balance control is negatively affected from the early stages of PD and worsen as the disease 
progress.
49
 As PD causes impairments of several physiological systems, balance impairments 
in individuals with PD cannot be explained by one single function but are rather the result of 
impairments of multiple systems. 
1.3.1.1 Movement strategies 
Balance impairment in individuals with PD is traditionally associated with poor or absent 
reactive responses following external perturbations.
50
 As an example, the quality of the 
balance reactions in the backward direction is actually used as disease severity criterion.
51
 
However, APA is also impaired in PD; thus leading to instability and decreased movement 
quality, for instance during postural transfers
52,53
 and gait initiation.
54,55
 Degeneration of the 
basal ganglia also leads to inflexible adaptation of motor commands, which is important for 
task and context-specific adjustments of movement.
56,57
 
1.3.1.2 Orientation in space 
Individuals with PD have demonstrated compromised perception of verticality of the body 
which increases the risk of falling.
58,59
 
1.3.1.3 Controls of dynamics 
Impaired gait occurs early on in PD, and comprises two types of disorders.
60
 Firstly, the 
continuous gait disorder that often includes decreased velocity, reduced arm swing, as well as 
short shuffling and variable steps.
60
 Secondly, individuals with PD might also demonstrate 
episodic gait disorders, such as festination and freezing. The latter is characterized by the 
inability of generating walking steps despite having the intention to walk.
61
 
1.3.1.4 Biomechanical constraints 
Several biomechanical constraints characterize PD, e.g. decreased joint range of motion, 
‘stooped’ posture, narrow foot stance and axial rigidity.50,62,63 These impairments degrade the 
ability of the body to control postural perturbations
50
 and restricts the functional limits of 
stability, i.e. the area in which the CoM can be moved with maintained stability and without 
changing the BoS.
64
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1.3.1.5 Sensory information 
Dysfunction of the basal ganglia influences the re-weighting and integration of sensory 
information which degrades the ability of adapting to different sensory environments.
37
 For 
individuals with PD, this problem is accompanied by impaired proprioception,
37,65
 
overestimation of the amplitude of movements
66
 and over-reliance on vision for balance 
control.
67
 
1.3.1.6 Cognitive processing 
Dual-tasking leads to degraded balance and gait performance in individuals with PD,
46,52,68
 
resulting in vulnerability to falls during many daily activities.
69,70
 Considering walking, most 
previous studies have demonstrated a decrement of ≥20% in walking velocity between ST 
and DT in PD,
46
 compared with only 5-10% in healthy individuals.
71
 Furthermore, it is likely 
that non-motor symptoms, in particular impaired executive functions (i.e. cognitive abilities 
that control goal-directed behavior),
72
 interfere with balance control in individuals with 
PD.
44,45,72
 Both the bottleneck and capacity-sharing theories have been applied to explain DT 
interference in individuals with PD.
45,46
 
1.3.2 Turning while walking 
Locomotion in everyday life is rarely performed during steady state walking; in fact, up to 
50% of the steps executed each day incorporate turning steps.
73
 In this thesis, turning is 
conceptualized within the ‘control of dynamics’ domain of balance control, and is defined as 
movements that lead to a change in direction of the body with respect to the longitudinal axis. 
In particular, this work accentuates turning that takes place while walking and which 
according to Patla et al, this task incorporates re-orientation of the body towards the new path 
and adaptation of the ongoing step cycle.
74
 
Walking turns have been divided into two strategies, either step strategy (turning to the 
opposite side of the stance leg, e.g. turning right with the right foot and the left foot is on the 
ground) and spin strategy (turning towards the stance leg, e.g. turning right with the left foot 
and the right foot is on the ground).
75
 From a balance control point of view, the step strategy 
offers greater stability owing to a wider base of support compared with the spin strategy.
75,76
 
Turning is a complex task that integrates spatial awareness and dynamic control of 
CoM,
74,75,77
 which is especially apparent during community ambulation since turning is 
frequently executed unexpectedly with limited time for planning (e.g. negotiating obstacles 
and navigating crowded environments).
78,79
 
1.3.3 Turning impairments in Parkinson’s disease 
Turning impairments is a common feature of gait disturbance which is, for many, a trigger to 
freezing of gait and falls.
80-82
 Turning deficits in PD often appear before any changes in linear 
walking can be observed,
83
 and are characterized by impaired axial coordination
84-86
 and the 
requirement of a greater number of steps.
86-88
 Even if turning difficulties increase with disease 
progression, more than 50% of subjects with mild to moderate stage of PD report turning 
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problems.
82,89
 In a recent study by Mancini et al., the authors demonstrated that for 
individuals with PD, an average turn in daily living included three turning steps, resulting in a 
turning angle of approximately 90°.
90
 Laboratory studies have also shown that turning 
impairments in PD became more prominent while turning 120° compared to 60°.
85,91
 As 
cognitive distraction and stressful situations (e.g. tasks with limited time for planning) 
degrade dynamic balance control in individuals with PD,
61
 these aspect could be important to 
consider in the assessment of turning. 
1.4 EFFECTS OF BALANCE IMPAIRMENTS  
For individuals with PD, balance impairments have a negative impact on several domains of 
activities of everyday living, including limitations in activity and restrictions in participation 
according to the ICF. 
1.4.1 Falls and fall-related psychological issues 
Among the negative effects of balance impairments in individuals with PD, falls are the most 
alarming due to the devastating consequences of these events. In fact, compared with healthy 
individuals, elderly with PD have shown a nine times increased risk of injurious falls
82
 
accompanied with high mortality and costs in the general older population.
92,93
 Furthermore, 
among individuals with PD, falls commonly occur while tripping, turning, reaching and 
rising,
81
 with impaired balance control as one of the critical factors of the etiology of falls.
94
 
Regardless of whether a person experience falls or not, or if physical injury occurs, falls or 
near fall events often lead to fall-related psychological issues, such as fear of falling, concerns 
about falling and loss of balance confidence.
4,95
 Although these psychological constructs are 
similar, they are believed to represent unique information with regard to their impact on falls, 
activity and participation.
4
 For individuals with PD, cross-sectional studies have revealed that 
fall-related psychological issues are associated with impaired balance performance, 
dependency in daily activities, fatigue and poorer quality of life.
96-98
 Furthermore, fall-related 
psychological issues have shown to be a barrier to exercise
99
 and an independent predictor for 
future falls.
100
 
1.4.2 Activity limitations  
For individuals with PD, the wide variety of symptoms, including balance impairments, 
induces different limitations in activity, such as transfers, walking, eating and 
communicating.
101,102
 Activity limitations in PD are also linked to other negative features, 
such as decreased quality of life
103
 and decreased physical activity.
104
 Physical activity is an 
important aspect to consider in the management of individuals with PD due to the risk of 
inactivity that is precipitated by a decline in physical functioning (i.e. decreased muscular 
strength, joint range of motion, aerobic capacity), and increased risk of co-morbidity (e.g. 
cardio-vascular diseases).
105,106
 In this thesis, the term level of physical activity is used to 
address the habitual physical activity (i.e. the sum of all activities a person does as part of 
their regular day).
107
 Previous studies in individuals with PD have shown about 30% lower 
levels of physical activity, compared with healthy individuals of the same age.
108,109
 Higher 
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disease severity and impaired gait performance have been associated with lower physical 
activity levels in this population.
108,109
 Older individuals with PD are at risk of inactivity, not 
only because of increased age, but also due to the motor and non-motor symptoms of PD 
contributing to sedentary behaviour. 
1.5  TREATMENT FOR PARKINSON’S DISEASE 
1.5.1 Effects of dopaminergic medication on balance impairments 
The effects of dopaminergic medication on balance-related tasks are commonly addressed by 
evaluating the task performance in an ‘OFF’ and ‘ON’ medication state.110 In particular, OFF 
testing is commonly performed after overnight withdrawal of medication, whereas ON testing 
is performed approximately one hour after taking the prescribed medication. Importantly, this 
is a pragmatic approach where the performance of a certain task is compared between a 
condition when medication wears off and symptoms recur (OFF) and a second condition 
when the individual experience a favorable response to medication (ON). 
Although dopaminergic medication has a dramatic clinical effect on PD,
24
 the effects of 
medication on balance control remains uncertain.
28
 One reason for this uncertainty is the 
divergent effects that dopaminergic medication has on impairments as well as different 
domains of balance control.
111
 First of all, regarding body functions, medication has showed 
to improve bradykinesia of the limbs in individuals with PD,
112,113
 while axial rigidity and 
proprioception remained ineffectively addressed by medication.
62,65
 Secondly, several studies 
have demonstrated that dopaminergic medication led to faster walking velocity owing to 
longer steps
111,114-116
 as well as improved performance on clinical balance tests.
115,117
 In 
contrast, other important domains of balance control, such as postural adjustments
118,119
 and 
postural sway,
111,120,121
 have showed to be negatively affected by medication.  
Previous studies on the effects of medication on turning in individuals with PD investigated 
in-place turns
62,122-124
 and walking turns.
111,125
 Independent of the type of turn evaluated, the 
studies have demonstrated inconsistent results, varying from no improvement
62,122,124,125
 to 
slight improvements.
111,123
 Furthermore, those studies focused mainly on global performance 
measures (e.g. turning duration). Therefore, limited knowledge exists regarding the effects of 
medication on specific features influencing turning performance, e.g. how turning is initiated 
and the manner in which the walking pattern is regulated while turning. As such, information 
concerning the effects of and features not addressed by medication is needed to first 
understand the medication effects, or non-effects, and secondly to guide training 
interventions.
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1.5.2 Balance training 
1.5.2.1 Exercise modalities 
Exercise is defined as ‘a physical activity that is planned, structured and repetitive with the 
objective to improve or maintain physical fitness components’.6 According to the European 
Physiotherapy Guideline for Parkinson’s disease, training interventions addressing balance 
impairments in PD could be divided into three broad and partly overlapping categories: 1) 
Exercise: that target balance-related impairments directly, e.g. through walking or transfer 
exercise, or indirectly through strength and aerobic exercise; 2) Movement strategies: the 
application of cognitive strategies (i.e. cueing, attention and sequencing) to daily activities in 
order to compensate for deficits in movement automaticity, and 3) Practice: entails repetitive 
motor execution to improve the fluency of motor skills, either of original motor skills or 
through motor learning of novel skills.
23
 
1.5.2.2 Effects of balance exercise 
Although there is a growing body of research demonstrating that balance impairments in 
individuals with PD improves by use of different exercise modalities, no current evidence 
that suggests the effectiveness of one specific training modality over the other is 
available.
23,126,127
 Furthermore, it remains unclear whether or not the positive effects of 
exercise on balance related outcomes (e.g. clinical balance tests) are further transferable to 
activities of daily living.
126,128
 Based on a meta-analysis of exercise interventions targeting 
balance performance in PD, it was recommended that future exercise interventions should 
focus on more challenging aspects of balance exercises and consist of a higher training 
dose.
127
 
1.5.2.3 Dual-task exercise 
The focus of this thesis is on balance exercise within the practice domain, which aims to 
optimize motor learning by gradually increasing task and context complexity as well as 
cognitive engagement.
23
 The most common approach in the management of PD within this 
domain is integrated DT training, i.e. two tasks (e.g. a motor and a cognitive task) are 
practiced at the same time.
45,129
 Exercise that contains DT has several potential benefits for 
individuals with PD such as the concurrent training of motor and cognitive impairments (e.g. 
executive functions) under conditions that realistically resemble activities of everyday 
living.
45
 Based on the often cited recommendations in PD evidence-based rehabilitation, a 
recent shift from emphasizing avoidance of DT
130
 to recommending DT exercise as safe and 
effective in the mild to moderate stage of PD (H&Y 2-3) has been proposed.
23
 Still, evidence 
on DT training in PD is limited. To date, we have previously showed that DT training is 
feasible in older adults with PD
131
 and other pilot studies have indicated improved gait 
performance after DT-training in PD;
129,132-134
 however, hitherto no randomized controlled 
trial confirmed those effects. 
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1.5.2.4 Validity of balance exercise programs 
Training interventions targeting balance impairments are often based on frameworks that 
include theoretical principles that underpin and guide the practical execution of training. 
Similar to the description by Nilsen, a framework often includes a structure or plan consisting 
of various categories, e.g. concepts, constructs or variables, and importantly, frameworks do 
not provide explanations; they only describe empirical phenomena by fitting them into a set 
of categories.
135
 
The transferability of a framework into practice could be considered to be an important aspect 
of internal validity. If uncertainty exists regarding the transparency between the framework of 
a training intervention and its practical implementation, it may be impossible to conclude 
whether certain characteristics of training were responsible for the efficacy of the 
intervention. Such uncertainty also compromises the comparison between clinical trials when 
synthesizing evidence.
136
 
To prevent balance impairments and to promote motor learning in PD, it is recommended that 
training follows the principle of progressive overload, i.e. provide a challenging overload to 
the physiological system at a certain level of intensity and regularity.
137
 In practice, this 
denotes that training should reflect the limits of individual capacity with a gradual increase of 
training load over time.
137
 However, the transferability of this principle to practice is 
problematic, partly due to the complex nature of this intervention. To exemplify this 
complexity, no established criteria exist on how to monitor and progress balance training,
138
 
contrasting for example strength and aerobic exercises. Instead, the adaptation of balance 
exercise commonly relies on the trainer's ability to assess the performance of exercise and 
accordingly adapt the level of difficulty.
138
 In contrast to such a subjective approach, it would 
be valuable to apply objective measurement to certain characteristics of balance training.
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Figure 4. The main concepts in this thesis and their hypothesized interaction.  
1.6 RATIONALE 
Deterioration of balance control is a critical component in the downward spiral of activity 
limitations,
101,102
 decreased physical activity,
104,108
 concerns of falling
97,98
 and falls in 
individuals with PD (Figure 4).
97,98
 Falling occurs predominantly during dynamic transfers, 
and individuals with PD are at especially high risk of falling while performing turns.
80,81
 
Dopaminergic medication, the primary option of PD treatment, improves overall mobility in 
individuals with PD, but little is known about the precise effect of this treatment on walking 
turns. 
The provision of appropriate exercise interventions for individuals with PD is one way to 
combat balance impairments and sedentary behavior in this group. Exercise interventions 
have not only the potential to postpone functional decline, but can also prevent adverse events 
related to inactivity.
105,106
 In relation to training interventions, the mild to moderate stages of 
the disease are of specific interest since mobility impairments and falls are present and 
individuals are still independent ambulators. Owing to the preserved motor learning abilities 
in the mild to moderate stages of PD,
139
 individuals are recommended to engage in exercise 
which challenges both motor and cognitive functions (e.g. DT-exercise).
23
 Although pilot 
studies have showed positive effects of DT-exercise in PD,
129,132-134
 no randomized controlled 
trial has yet confirmed these effects. Furthermore, although balance training programs are 
required to be progressive and highly-challenging, it remains unclear whether these principles 
can be achieved in the practical execution of training. 
This thesis aims to address current gaps in the literature by investigating the efficacy of a 
highly-challenging balance intervention program in individuals with PD as well as the ways 
in which dopaminergic medications affect turning impairments in this group. In doing so, 
study findings can be expected to inform the development and implementation of effective 
training interventions which target disease-related balance impairments in PD and the 
sustenance of independent living among these individuals. 
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2 AIM 
The aim with the experimental part was to investigate the effects of dopaminergic 
medications on turning while walking in older adults with mild to moderate PD. The clinical 
part aimed to develop a training program targeting balance impairments related to PD, to 
verify the progression of this program and the specific effects on balance and gait, as well as 
the transfer effects to everyday living. 
 
Specific aims 
Study I: To investigate the effects of dopaminergic medication on the initiation and 
performance of preplanned and unplanned walking turns in older individuals with mild to 
moderate PD compared to a healthy control group. 
Study II: To develop a novel progressive balance training program that emphasises highly- 
challenging and varied balance exercises, including DT, specifically related to PD 
impairments. 
Study III: To explore the intended progression of a 10-week balance program, including DT, 
in two independent training groups of older adults with mild to moderate PD. 
Study IV: To investigate the short-term effects of a 10-week training program with highly-
challenging balance exercises, including DT, compared with usual care in older adults with 
mild to moderate PD. In particular, the aim was to evaluate if this program led to specific 
effects on balance and gait, and whether these effects would also transfer to everyday living 
(concerns about falling, physical activity levels and activities of daily living). 
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3 METHODS 
3.1 DESIGN 
The experimental part contains a cross-sectional study (Study I), while the clinical part 
contains a study protocol (Study II), a longitudinal observational study (Study III) and a 
randomized controlled trial (Study IV). 
3.2 SAMPLE SIZE AND POWER 
For Study I, the sample size was based on previous studies that included approximately 20 
individuals with PD and controls, respectively, to assess the effects of dopaminergic 
medication on turning, balance control and gait.
115,123
 For the Randomized controled trial 
(Study II and IV), the sample size estimation was based on a pilot study
131
 and similar 
intervention studies in PD.
132,140
 The power calculation was performed separately for the 
three main outcome measures: balance performance assessed with the Mini Balance 
Evaluation Systems Test (Mini-BESTest); gait velocity measured during ST and DT 
conditions; and concerns of falling evaluated with the Falls Efficacy Scale–International 
(FES-I). In order to achieve 80% power with a 2-sided alpha level of 5%, the number of 
subjects required per group and the hypothesized effect size (ES) were 24 (ES = 0.83) for 
Mini-BESTest, 27 (ES = 0.83) for gait velocity and 32 (ES = 0.71) for FES-I. Altogether, by 
taking into account an anticipated dropout rate of 15%, a sample size of 40 in each group was 
needed (total n = 80). However due to long-term follow-up of the training program (not 
included in this thesis), the group size was increased to 50 subjects (total n = 100). Due to the 
exploratory nature of study III, no power calculation was considered necessary prior to this 
study. 
3.3 PARTICIPANTS 
3.3.1.1 Recruitment 
All participants in the three studies were recruited for and derived from the BETA-PD study. 
Community-dwelling individuals with Parkinson’s disease were recruited via advertisements 
in local newspapers, the Swedish Parkinson Associations, Karolinska University Hospital and 
outpatient neurological clinics in Stockholm County. Approximately 70% of the participants 
with PD were recruited via advertisements, 10% from the health care system and the 
remaining 20% were unknown. Data for all studies were collected between spring of 2012 
and spring of 2013. An overview of the recruitment procedure, sample size and the dropout 
rates for all studies is provided in Figure 5. Furthermore, the participants’ characteristics for 
the different studies are presented in Table 2. 
3.3.1.2 Inclusion and exclusion criteria 
Inclusion criteria were: a clinical diagnosis of idiopathic Parkinson’s disease (Queens Square 
Brain Bank criteria);
16
 a H&Y-score of two or three;
21
 ≥60 years of age; the ability to 
independently ambulate indoors without a walking aid; ≥3 weeks of unchanged dopaminergic 
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medication and signs of impaired balance control (e.g. instability during postural transfers 
and gait impairments) during baseline clinical assessment. This approach attempted to 
simulate the real-world in that individuals with such disease profiles would be considered for 
physiotherapy in clinical practice. 
Exclusion criteria were: cognitive deficits as indicated by a Mini-Mental State Examination 
score of <24,
141
 and other medical conditions that would substantially influence balance 
performance or participation in the intervention. Specific exclusion criteria for study I were 
visual impairments, severe tremor and medication-induced dyskinesia affecting walking. In 
study I, healthy individuals (matched for age- and gender) were recruited through 
advertisement and senior training groups in Huddinge, Stockholm, to serve as a control 
group. The control subjects had no visual impairments or any medical condition affecting gait 
or balance performance. 
3.3.2 Study I 
In this experimental study, 20 individuals with PD and 20 healthy control subjects were 
assessed for eligibility. One individual with PD was excluded due to severe medication-
induced dyskinesia and three in the control group due to visual impairment, imbalance due to 
vertigo and gait problems. Data from 19 individuals with PD and 17 healthy controls were 
analyzed. 
3.3.3 Study III 
A sub-group of individuals with PD that have been allocated to the training group in study IV 
was recruited to this study. This group represented two training groups, with the first that 
trained as part of the south cohort (n = 6) and the second as part of the north cohort (n = 4). 
3.3.4 Study IV 
Participants that have met the criteria for inclusion were divided into two geographic cohorts 
(south and north). After baseline testing, the participants in each cohort were randomized in 
blocks of four to either a training-group or control-group. The random sequence for group 
allocation was performed by one of the study coordinators (DC) using web-based software 
(http://www.randomization.com). Opaque envelopes, both sealed and numbered, were used 
to ensure that both testers and participants were blinded to the group allocation. Masking of 
the test leaders was not possible after baseline assessments because some also served as 
trainers during the balance training intervention. However, during the 10-week follow up 
assessments, we ensured that participants were never assessed by a test leader who had been 
involved in their training. A total of 100 participants with PD were randomized, and 91 
participants completed the 10-week follow up. The dropout rate and reasons for discontinuing 
participation in the study were similar in both groups (Figure 5). 
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Figure 5. Flowchart illustrating the recruitment, enrolment and sample sizes for Study I, III and IV, as 
well as the randomization, follow-up and reasons for withdrawal from Study IV. 
Abbreviations: PD = Parkinson’s disease; H&Y = Hoehn and Yahr; MMT = Mini Mental State 
Examination. 
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Table 2. Background characteristics of the participants. Continuous data presented as mean (standard deviation) and min-max; nominal data is 
presented as numbers (percentages).  
 Study I  Study III  Study IV 
 PD (n=19) Healthy controls (n=17)  PD training (n=10)  PD training (n=47) PD control (n=44) 
Variable Mean (SD) Min─Max Mean (SD) Min─Max  Mean (SD) Min─Max  Mean (SD) Min─Max Mean (SD) Min─Max 
Age, yrs 72 (4) 65─82 72 (5) 65─87  71 (6) 63─83  73 (6) 61─87 74 (5) 65─87 
Body weight, kg 75 (11) 58─92 76 (9) 61─94  83 (12) 57─101  76 (14) 48─102 77 (14) 45─101 
Body height, cm 173 (6) 158─182 176 (9) 159─187  173 (9) 160─187  172 (9)  156─190 171 (9) 148─187 
UPDRS motor  35 (8) 18─49 - -   40 (7) 31─50  36 (10) 17─62 37 (11) 14─57 
PD duration, yrs 5 (4) 1─17 - -  4 (2) 1─7  6 (5) 1─25 6 (5)   1─21 
LEDD,
a
 mg/day
 
636 (228) 200─1102 - -  479 (387) 0─1298  581 (295)  0─1487 645 (404) 225─2666 
Gait speed, m/s 1.24 (0.13) 0.83─1.39 1.47 (0.14) 1.23─1.73  1.18 (0.21) 0.80─1.53  1.19 (0.21) 0.73─1.55 1.16 (0.18) 0.67─1.52 
Average steps/day  5886 (3637) 774─14130 - -  4632 (3496) 781─10696  4842 (3046) 376─13436 4695 (3397) 149─14495 
 Numbers % Numbers %  Numbers %  Numbers % Numbers % 
Gender, male  12 63 10 59  7 70  28  60 23  51 
H&Y stage, 3 4 21 -   4 40  27  57 25  57 
Recurrent fallers,
b
 yes 11 58 0 0  6 60  25 53 24  55 
<5,000 steps/day 9 47 - -  6 60  25 54 26 59 
Abbreviations: PD = Parkinson’s disease; H&Y = Hoehn and Yahr; UPDRS = Unified Parkinson’s Disease Rating Scale; LEDD = Levodopa equivalent daily dosage.  
a Daily levodopa dose equivalency calculated in accordance to Tomlinson et al. (2010).142 
b Participants who had experienced ≥ 2 falls during the previous 12 months were classified as recurrent fallers. 
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3.4 DATA COLLECTION 
According to the wide disability spectrum associated with balance impairments in PD 
49,143,144
 
a multi-dimensional battery of outcomes were measured to explore different domains of 
balance impairments and treatment effects. Table 3 provides a classification of outcomes 
measures used in this thesis within the ICF.
1
 
 
Table 3. Classification of outcome measures within the International Classification of Functioning, 
Disability and Health (ICF). 
  ICF 
 
Instruments  
 
Domains 
Body 
functions Activity Participation 
Study I     
Motion analysis 
system 
Turning characteristics (onset, strategy 
and performance). Spatial gait parameters 
during straight walking and turning.  
• •  
UPDRS-motor Motor symptoms •   
PIGD Balance control • •  
Medication-VAS Self-perceived mobility impairments  •  
Study III     
Accelerometer Training activity  •  
Study IV     
Mini-BESTest Balance control • •  
MFE-test Balance control  •  
Electronic 
walkway 
Temporal and spatial gait parameters 
during ST and DT conditions 
• •  
Cognitive task Executive functioning •   
FES-I Concerns about falling •   
UPDRS ADL Activities of daily living  •  
Accelerometer Physical activity level  • • 
Abbreviations: FES-I = Fall Efficacy Scale International; Mini-BESTest = Mini Balance Evaluation Systems Test; MFE = 
Modified Figure-of-Eight test; ST = single-task; DT = dual-task; UPDRS motor = the motor section of the Unified 
Parkinson’s Disease Rating Scale, part III; UPDRS ADL = the activities of daily living (ADL) section of the Unified 
Parkinson’s Disease Rating Scale, part II; PIGD = Postural Instability and Gait Difficulty four-item sub-score; VAS = visual 
analogue scale. 
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3.4.1 Severity of Parkinson’s disease 
The motor section of the Unified Parkinson’s Disease Rating Scale motor score (UPDRS-
motor) was used to assess motor symptoms (i.e. tremor, rigidity, bradykinesia, postural 
instability and gait).
21,145
 The UPDRS-motor section contains 27 items which are summarized 
as a sum-score (maximum score equals 108 points), where a higher score indicates more 
severe symptoms. The UPDRS-motor has proven to be valid and reliable in several studies 
51
. 
From the UPDRS-motor assessment, disease severity of PD was classified according to the 
original H&Y staging scale,
21
 with the use of disease duration (years) and daily levodopa 
equivalency daily dose (LEDD)
142
 as additional proxies for disease severity. 
3.4.2 Turning while walking 
3.4.2.1 Test procedure 
The PD group was tested twice, first after overnight withdrawal of medication (OFF, average 
off time = 16 hours, range: 12-22 hours) and approximately one hour after taking their usual 
morning dose of dopaminergic medication (ON). The mean LED (min-max) intake following 
OFF testing was 194 milligram (50-380) which on average represented 31% (17-71%) of 
their daily dosage. 
Since it was not feasible for many participants to attend assessments over two days, both test 
sessions were performed on the same day. Before each test session (OFF and ON), the 
UPDRS-motor was administrated by a physiotherapist trained to assess motor impairments 
under both medication conditions. After OFF and ON testing, participants rated how well 
their medication was working using a 100 mm visual analog scale (i.e. 0 mm equals worst 
possible effect while 100 mm equal best possible effect).
122
 
The control group also underwent a protocol comprising two sessions. First, turning was 
assessed at comfortable walking velocity, and thereafter the same protocol was then repeated 
where the walking pace was matched to a comfortable pace of the PD participants. For the 
majority of the control subjects, the matched velocity was achieved by instructing controls to 
walk slower than their comfortable speed. The test leader also paced the control subjects by 
using a handheld stopwatch and by counting the number of steps over a two-meter distance. 
This matching approach was applied because walking velocity alone can influence movement 
characteristics during straight walking
146
 and turning.
84,147,148
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Figure 6. Schematic drawing of the walking alley, position of the reflective markers and the global 
reference system used. The walking direction (straight, right or left) was provided with a visual signal 
before walking initiation during preplanned turns and 0.6 meter prior to the intersection point during 
unplanned turns. 
 
3.4.2.2 Preplanned and unplanned turning 
Prior to data collection, practice sessions were held to familiarize participants with the 
procedure. The PD and control group performed two different turning conditions (preplanned 
and unplanned) in a randomized order. 
For both turning conditions, the participants walked along a 9-meter T-shape walking alley 
where the turning position was delineated by two poles forming an intersection (see Figure 
6). For both preplanned and unplanned turns, they performed one of three tasks, presented 
randomly: walking straight, or walking and turning 180° to the right or to the left. Subjects 
were instructed to walk and turn to the new direction without stopping whilst, taking the 
closest path to the target (defined by two poles, located 2.15 meter laterally and 1.0 meter 
behind the intersection). The subjects started each trial 4.85 meters from the turning 
intersection, thus providing a sufficient distance to reach a steady-state straight walking 
velocity before turning.
149
 For the preplanned condition, the walking direction was provided 
by a visual signal before they initiated walking (i.e. while standing at the starting position) 
denoting that planning of the walking direction takes place prior to trial being executed. In 
contrast, for the unplanned condition, the same visual signal was provided 0.6 meter prior to 
the intersection point (i.e. during steady-state walking).
150
 Consequently, for the unplanned 
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condition, participants had approximately one step length to plan and initiate turning. The 
pre- and unplanned turning condition each contained a total of 15 trials per subject (i.e. five 
trials each for straight walking, right and left turning). During testing, the participants were 
allowed to rest when needed. 
3.4.2.3 Measurement of movement 
Movements were recorder at 100 Hz using an eight-camera motion analysis system (Elite 
2002, version 2.8.4380; BTS, Milano, Italy). Spherical retro-reflective markers (1cm in 
diameter) were positioned on the seventh cervical vertebra (C7) and bilaterally on the head, 
acromion, posterior superior iliac spine and heel (Figure 6). As spatial references, two 
markers were also positioned on the two poles forming the intersection. Three-dimensional 
trajectories of the markers were acquired using a tracking system (Tracklab-BTS, Milan, 
Italy) in accordance with a global reference system: y-axis (up/down), z-axis (medial/lateral) 
and x-axis (anterior/posterior) (Figure 6). Data were processed and filtered (Butterworth low-
pass filter: 7-Hz cutoff frequency) using MATLAB software (MATLAB, 7.4.0, MathWorks, 
Natick, MA, USA, 2013). 
 
 
Figure 7. Representative footstep adjustments of two pre-turning steps and three turning steps. 
A) The first turning step (i.e. plum color) was identified as the first heel strike that exceeded two 
standard deviations in medio-lateral displacement of straight walking. B) Representative footstep 
adjustments for step turns (i.e. first turning step equal the turning direction) and spin turns (i.e. first 
turning step opposite to the turning direction) are also illustrated. Notable is the wide and narrow base 
of support for the first turning step of a step and spin turn, respectively. 
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3.4.2.4 Turning outcomes 
Three turning steps were analyzed, which is typical for turns in daily living (approximately 
90°).
90
 As shown in Figure 7a, heel strikes for two steps leading into and three steps exiting 
the turns were collected. Heel strike events were determined based on the velocity profiles of 
the heel markers (y-axis). The pre-turning steps were used as a baseline to determine onset of 
the first turning step,
148
 and for the calculation of step length and width of the turning steps.
151
 
The turning steps were identified as the first heel strike that exceeded two standard deviations 
(SD) in medio-lateral displacement of five straight walking trials (computed for each 
participant) in the designated turning direction (see Figure 7a). To discriminate between 
preparatory turning steps and the actual turning step, the succeeding turning step also needed 
to exceed two SD from the straight walking trial average.
148
 A turn was defined as a step turn 
if the first turning step was performed in the direction to turning or as a spin turn if the first 
turning step was the opposite to the direction of turning (see Figure 7b).
75
 The outcomes for 
turning are explained in Table 4. 
 
Table 4. Outcomes for walking turns. 
Outcomes Description 
Turning strategy The percentage of turning trials using the step strategy, i.e. the number of 
trials using step turns divided by the total number of trials. 
Body rotation The yaw angular displacement profile of the pelvis segment was calculated 
and the magnitude of pelvis rotation at the third turning step was retained for 
analysis. 
Turning distance The cumulative linear displacements in metres of the C7 marker [z and x-
axis] for three turning steps. 
Turning velocity The first derivative of the tangential displacement of the C7 marker was 
calcutated and the mean velocity of three turning steps was analyzed. 
Turning trajectory The mean distance in metres between C7 and the markers positioned at the 
turning pole using three turning steps. 
Spatial gait 
parameters 
Step length and width of three turning steps were calculated in accordance to 
Huxham et al.
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3.4.3 Balance control 
Balance control was assessed with the Mini-BESTest, which is a 14-item clinical test that 
covers four components of balance control (anticipatory postural adjustments, postural 
responses, sensory orientation, and stability in gait).
152
 Each item is scored on a three level 
ordinal scale from 0 (unable or requiring help) to 2 (normal) and the result is summarized as a 
total score (maximum score of 28 points).
153
 The Mini-BESTest has shown to be reliable and 
valid for older adults with mild to moderate PD.
154,155
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The Modified Figure-of-Eight (MFE) test was also used to assess balance control.
156
 During 
testing, the participants were instructed to walk two cycles in a figure of eight (marked with 
40 mm-wide tape on the floor, each loop having an internal diameter of 1.63 m) as fast as 
possible, with every step touching the tape. The test was performed twice where the average 
time (seconds) and number of oversteps (i.e. steps not touching the tape) were used for 
analysis. The MFE-test has shown to be reliable and valid for older healthy adults.
156
 
In addition, the Postural Instability and Gait Difficulty (PIGD) four-item sub-score was 
calculated from the Motor UPDRS (i.e. arising from a chair, standing posture, gait and pull 
test).
111
 
3.4.4 Single and dual-task gait 
Gait characteristics were assessed with a 9-meter electronic walkway system, GAITRite® 
(CIR Systems, Inc., Havertown, PA, USA), during normal walking and while performing an 
additional cognitive task (reciting every second letter of the Swedish alphabet), i.e. DT. The 
participants were instructed to walk at a normal pace under both conditions, and to place 
equal focus on the walking and the cognitive task during DT. Each gait condition was 
performed six times, and an average value was used for analysis. Gait outcomes were gait 
velocity (m/s), step length (m) and cadence (steps/min). The GAITRite® mat is valid and 
reliable for the assessment of spatial and temporal gait characteristics.
157,158
 
To gain more insight into DT performance, the performance of the cognitive task during 
walking (DT) and as a ST while seated was also evaluated. For the performance of the 
cognitive task, percentage of errors (i.e. the number of errors / total number of letters recited) 
was used for analysis. 
3.4.5 Concerns about falling 
Concerns about falling, a subdomain of fall-related psychological issues,
4
 were assessed with 
the Swedish version of the FES-I.
159
 The FES-I is a questionnaire assessing how concerned 
people are about falling during 16 indoor, outdoor and social activities. Participants grade 
"how concerned" they are while performing the activities on a 4-point scale, i.e. from "not at 
all concerned" to "very concerned"). A total score is calculated (ranging from 16 to 64), and 
higher scores indicate greater concerns about falling.
159,160
 The FES-I has shown to be valid 
and reliable for older individuals with PD.
161
 
3.4.6 Falls 
Fall frequency over the last 12 months was retrospectively reported, using structured 
questions. A fall was defined as an unexpected event in which the participants came to rest on 
the ground, floor, or lower level.
162
 Fall data were descriptively presented, and individuals 
who experienced ≥2 falls during the previous 12 months were classified as recurrent fallers.82 
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3.4.7 Activities of daily living 
Activities of daily living were assessed with the second part of the Unified Parkinson's 
disease rating scale (UPDRS-ADL).
145
 The UPDRS-ADL is a 13-item questionnaire focusing 
on the effects of PD on various daily activities (e.g. speech, handwriting, getting dressed, 
freezing of gait, hygiene and walking). Concerning each item, an interviewer records the self-
rated score on an ordinal scale ranging between 0 and 4 (0 = no problems; 4 = severe 
problems).
21
 The result is summarized into a total score (0-52), where a higher score indicates 
more limitations. The UPDRS-ADL has shown to be valid and reliable for PD.
163,164
 
3.4.8 Physical activity and training activity 
Physical activity during daily living and balance training was measured using accelerometers 
(Actigraph GT3X+, Pensacola, FL, USA). The GT3X+ accelerometer records the 
acceleration in three axes: vertical, antero/posterior, and medio/lateral. Accelerometry data 
are stored in the units of gravity (g) and is subsequently transformed into an arbitrary unit (i.e. 
counts) in either axes or as a combined vector magnitude (VM).
165
 Participants worn the 
accelerometer around the hip, attached slightly above the iliac crest with an elastic band. Data 
were sampled at 30 Hz and processed using the ActiLife 6 software (ActiGraph, Pensacola, 
FL). The ActiLife default filter was applied,
166
 and data were summarized in 15-second 
epochs. The GT3X+ has been proven reliable and valid in assessing energy expenditure in 
healthy adults.
167
 
Physical activity during balance training (Study III): The participants were equipped with 
accelerometers during all training sessions, i.e. data collection consisted of 30 sessions that 
lasted 60 minutes. The position of the accelerometer was checked by the physiotherapists 
before and during the training sessions. As proxies for training activity, the number of steps 
per session and the time (in minutes) spent walking at a velocity of >1.0 m/s, were used to 
reflect the volume (e.g. walking, stepping) and intensity of the dynamic exercises, 
respectively. The number of steps per session was derived from the vertical axis (using a 
default logarithm in the ActiLife software) and the time spent walking at a velocity of >1.0 
m/s was based on VM cut-points developed for PD.
168
 
Physical activity levels in daily living (Study IV): Participants were instructed to wear the 
accelerometer in their daily life for seven consecutive days, only removing it when 
showering, swimming, bathing and at night. Participants were also asked to record on a log 
sheet the exact times the device was worn (i.e. wear time). Physical activity data were 
validated by comparing the accelerometer data with self-reported wear-time. Participants with 
four or more valid days were included in the analysis since it has shown to be a valid and 
reliable indicator of free-living physical activity in adult and elderly populations
169,170
 and 
PD.
171
 In order for a day to be considered valid, we required data of at least nine hours (> 90 
consecutive minutes of zeros was considered non-wear time).
169
 As a proxy for the level of 
daily physical activity, the average number of steps per day was used.  
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Training and leisure activities in the control group (Study IV): After the intervention period, 
participants retrospectively reported whether they had participated in organized training and 
performed leisure activities that aimed at altering physical activity during the intervention 
period. The type of exercise/activity was reported, as well as their mean frequency per week.  
3.4.9 Cognitive function 
The Mini Mental State Examination score was used as a screening tool for inclusion, where 
individuals were excluded if they scored <24 points.
141
 
3.5 TRAINING INTERVENTION 
3.5.1 Development 
The training program was developed, through discussions and workshops, by a group of 
researchers and physiotherapists, each with different expertise in the fields of PD, 
rehabilitation, and athletic training. This initial step led to a preliminary program, which 
feasibility was investigated in five older adults with mild to moderate PD in a University 
hospital setting.
131
 Findings from this study supported the feasibility of highly-challenging 
group balance training in older adults with PD.
131
 Still the participants found the program 
being too long; therefore to ensure a high level of motivation without decreasing the training 
dose, the length of the program was condensed from 12 to 10 weeks and the duration for each 
training session was increased from 45 to 60 minutes.
131
 
3.5.2 Rationale 
The rationale for the program relied on findings of preserved motor learning in mild to 
moderate PD
139
 and was based on the motor learning principles of specificity, progressive 
overload and varied practice. 
3.5.2.1 Specificity 
Training need to be specific to the targeted function.
9
 Accordingly, in the context of balance 
training, balance exercise needs to target functions, or impairments, of balance control 
associated with PD symptoms. 
3.5.2.2 Progressive overload 
Training needs to provide a challenging overload to the physiological system through a 
certain level of intensity and regularity.
9
 To stimulate relearning of physiological systems 
important for balance control, it is important to consider the training stimuli with regard to 
intensity of the training, the difficulty level of balance exercises and the total training dose. 
3.5.2.3 Varied practice 
Training need to promote variation between exercise conditions.
172
 To enhance motor 
learning, promote a multi-faceted repertoire of movement strategies and generalization of 
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balance skills to activities of daily living; it is essential to guarantee practice through a wide 
variety of balance exercise conditions.
9,172
 
3.5.3 Applications of theoretical principles in practice 
The training principles of specificity, progressive overload and varied practice were 
incorporated into a conceptual framework for balance training.
173
 The practical application of 
each training principle for balance training and motor learning is outlined below. 
3.5.3.1 Specificity 
Inspired by King and Horak,
174
 this framework comprises four specific balance components 
associated with balance constraints in PD (Table 5). In order to target a unique domain of 
motor control deficits in PD with each balance component, the principles and objectives of 
the different balance components were distinctively defined (Table 5). In addition, DT-
exercises were gradually integrated into the program by adding concurrent cognitive (e.g. 
counting, remembering items/numbers) and/or motor tasks (e.g. carrying and/or manipulating 
objects) to the balance exercises. 
3.5.3.2 Progressive overload 
Based on previous recommendations,
127
 balance training in elderly
175
 and experience from a 
pilot study of balance training in PD,
176
 a total training dose of 30 hours (i.e. three 1-hour 
sessions/week for 10 weeks) was considered feasible for elderly with PD as well as sufficient 
to accomplish the aims of motor learning. Training progression was promoted by the 
physiotherapists’ ability to adjust the level of difficulty of the exercises and structure of the 
training program.  
The physiotherapists adjusted the balance exercises based on the capacity of each training 
group as well as that of each participant. Specifically, the distribution between stationary and 
walking exercises was modified for the training group (i.e. walking exercises were considered 
to be more demanding), whereas the level of difficulty of balance exercises were adjusted for 
each individual (Table 5). The physiotherapists used two pragmatic principles for adaptation 
of balance training. For ST-exercises, the level of exercise difficulty was considered 
appropriate if the participants were forced to use reactive postural adjustments to control their 
balance. Similarly, the level of difficulty for DT-exercises was aimed at a threshold where 
there was consistent interference of the participants’ motor performance (e.g. decreased gait 
velocity or increased stride variation). 
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Table 5. Balance training. Parkinson’s disease specific balance components and the principles and objectives used for the practical application of each 
balance component, as well as the adjustments used for progression. 
Balance components Exercise principles Exercise objectives  Exercise adjustments 
Sensory integration    
Integration of sensory information 
(somatosensory, visual and 
vestibular) for estimation of body 
position  
Walking tasks on varying surface with or 
without visual constraints    
Improve interpretation of and reliance 
on somatosensory information 
Increased surface unevenness and 
restricted field of vision (e.g. by carrying 
an object) 
APAs    
Prediction and control of 
perturbation related to voluntary 
movements 
Voluntary arm/leg/trunk movements 
focusing on movement velocity and 
amplitude, and postural transitions  
Improve APA strategies regarding 
quality (timing, amplitude) and task- 
specific adaptation  
Increased movement amplitude and 
velocity 
Motor agility    
Coordination between body parts 
and movement adaptation, e.g. 
regulation of movement and quick 
shifts between tasks  
Whole-body coordination during varying 
gait conditions and reciprocal movements. 
Quick shifts of movement characteristics 
(velocity, amplitude and direction) during 
predictable and unpredictable conditions  
Improve whole-body coordination, 
ability to adapt movements and quick 
shifts between different tasks 
Increased gait complexity (e.g. altering 
velocity, step patterns) and amount of 
unpredictability (i.e. unawareness of 
upcoming sequences/tasks) of walking and 
coordination tasks.  
Stability limits    
Whole-body regulation relative to 
the BoS 
Voluntary leaning tasks in standing with 
varying BoS-stimulating weight shifts in 
multiple directions through arm and trunk 
movements 
Improve the ability to safely control 
CoM within BoS for increasing 
functional limits of stability 
Changing the area or condition of the BoS 
and increasing leaning movement 
amplitude. 
Abbreviations: PD= Parkinson’s disease; APAs = anticipatory postural adjustments; BoS = base of support; CoM = centre of mass. 
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Considering the structure of the program, the intervention period was divided into three 
blocks (A, B and C) to promote appropriate progressive overload throughout the course of 
training (Table 6). Importantly, individuals with PD, compared with healthy individuals need 
more time to achieve motor learning.
139,177
 Therefore progression of as well as variation in 
training was gradually increased throughout the 10-week program. 
Block A (weeks 1–2): participants were introduced to the ST exercises of each balance 
component separately (no DT-exercises were practiced), with an emphasis on movement 
quality, the objectives of the exercises, as well as task-specific motor learning. 
Block B (weeks 3–5): basic DT-exercises were introduced (i.e. cognitive or motor secondary 
task) and comprised approximately 40% of each session. While addressing each balance 
component separately during this block, the level of difficulty and task variation was 
increased. 
Block C (weeks 6–10): the level of difficulty of all exercises was further enhanced by 
increasing the variation by combining several balance components during exercise. 
Additionally for DT-exercise, motor and cognitive secondary tasks were combined during the 
same exercise session, difficulty level was further increased, and the time spent on DT-
exercises (approximately 60% of each session). 
3.5.3.3 Varied practice 
During the initial phase of training (Block A), the exercise for each balance component was 
trained separately in blocks, on a weekly basis, to encourage familiarity of the principles and 
objectives and promote task-specific motor learning. In the later phases of training (Blocks B 
and C), generalization of motor skills was facilitated by increasing training variation with 
regard to the characteristics of exercise in each balance component (e.g. variation in terms of 
body position, BoS and movement direction/velocity/amplitude) in Block B and by 
integrating exercises from different balance components in Block C. 
3.5.4 Practical execution of balance training  
Every training session started with a warm-up session of five minutes, consisting of varied 
walking tasks aimed at boosting the cardiovascular system. The following 50 minutes, 
including short resting periods, focused on highly-challenging exercise blocks (approximately 
10 minutes per block) of standing and walking conditions. The balance components of 
stability limits and APAs were mainly addressed through stationary exercises, whereas the 
balance components of motor agility and sensory integration were mainly addressed by 
walking exercise conditions. The program ended with a 5-minute cool-down session of slow 
walking, axial stretching and breathing exercises. The number of exercise blocks for each 
training occasion and the distribution between standing and walking exercises were adjusted 
to the level of ability in each group. 
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Goal-oriented oral feedback addressing information external to the body, i.e. concerning the 
performance of the task in relation to the environment (rather than the position or motion of 
the body), has shown to be beneficial for individuals with PD.
178,179
 Therefore, externally-
oriented oral feedback was given as simple as possible to promote movement automaticity. 
Cueing strategies (visual or oral)
180
 were only used when needed among participants 
experiencing severe freezing during training. 
Importantly, no fixed scheme of predetermined exercises was used in the intervention. 
Instead, the training principles were used as a foundation for the application and adaptation of 
exercises to the participants’ individual abilities. Consequently, this approach resembles 
clinical practice but also requires continuous evaluation, modification, and planning of the 
training. To ensure this, all the trainers involved in this study were physiotherapists (n = 10) 
educated in the framework of this training concept during two 4-hour sessions of both theory 
and practice. 
After each training occasion, the individuals’ performance of the exercises was briefly 
documented in terms of evaluating of both the appropriateness of exercises and the current 
level of difficulty. Adverse events (defined as an injury or medical event that restricted 
activities of daily living and participation in the intervention) and training adherence were 
monitored and recorded. 
 
Table 6. Training program divided into three blocks (A-B-C). The content of balance 
training for each week is illustrated with regards to the balance components and dual-task. 
Blocks Week Balance components Dual-task 
A 
1 Motor agility/stability limits  
2 Sensory integration/APAs  
B 
3 Motor agility/stability limits Cognitive 
4 Sensory integration/APAs Motor 
5 Motor agility/stability limits Cognitive 
6 Sensory integration/APAs Motor 
C 
7  
Sensory integration/APAs/motor 
agility/stability limits 
 
Cognitive / Motor 
8 Cognitive / Motor 
9 Cognitive / Motor 
10 Cognitive / Motor 
Abbreviations: APAs = anticipatory postural adjustments. 
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3.6 CONTROL GROUP 
The participants in the control group were encouraged to maintain their normal physical and 
daily activities and were not restricted from participating in ongoing rehabilitation programs. 
All participants were advised to keep up their normal level of exercise and activities 
throughout the intervention period. 
3.7 ETHICAL APPROVAL 
Ethical approval for this research was obtained from the Regional Board of Ethics in 
Stockholm (Dnr: 2006/151-31, 2009/819-32, 2010/1472-32, 2011/1665 22, 2012-1829-32). 
All studies were conducted in accordance with the Helsinki Declaration, and all subjects gave 
their written informed consent to participate. 
3.8 STATISTICS 
All statistical analyzes were conducted with STATISTICA software (Statsoft, version 12, 
Tulsa, OK, USA). Table 7 provides an overview of the descriptive and statistical methods 
applied in this thesis and across Study I, III and IV. The statistics tests applied in this thesis 
are detailed in text. 
Table 7. Statistical methods. 
  Experimental part  Clinical part 
Statistics applied  Study I  Study III Study IV 
Descriptive statistics      
Mean   ••  • •• 
Standard deviation  ••   •• 
Standard error     • 
95% confidence interval  ••   •• 
Median  •  •• •• 
Interquartile range  •  • •• 
Min - max  •  •• • 
Frequency (n), percentage (%)  ••   •• 
Statistical methods      
Independent t test     •• 
Mann-Whitney U test  •   •• 
Wilcoxon signed-rank test  ••  •• • 
Pearson's Chi-square test x
2
     • 
Fischer’s exact test  •   • 
Repeated measures ANOVA  ••   • 
Two-way ANOVA  ••    
Tukey’s HSD  ••   • 
Cohen’s d effect size  ••   •• 
Logistic regression analysis     • 
Abbreviations: ANOVA = Repeated measures analysis of variance; HSD = honestly significant difference. Black and 
grey dots indicate whether the statistical methods were applied in the manuscripts and in the thesis, respectively. 
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3.8.1 Study I 
The responsiveness to medication on self-perceived mobility impairments, PIGD-score, 
straight walking and turning performance were expressed as Cohen’s d effect sizes (ES).181 
Positive ES denote changes that are considered improvement.  
Mobility, gait and balance performance: Self-perceived mobility impairments (by means of 
VAS rating) and the PIGD-score were compared during OFF and ON medication using 
Wilcoxon signed-rank test. Straight walking velocity and step length were compared between 
PD OFF and ON using repeated measures analysis of variance (ANOVA). 
Turning strategy and performance: Data concerning turning direction and turning strategy 
were collapsed since no differences in turning performance between right and left turns, step 
and spin turns, or turning towards or away from the most affected side were found. Repeated 
measures ANOVA was used to evaluate the effects of medication (PD OFF and PD ON) and 
turning condition (preplanned and unplanned) on turning strategy and turning performance 
(i.e. body rotation, turning distance and velocity). Two-way ANOVA was used to evaluate 
the difference between groups (PD ON and controls) and turning condition (preplanned and 
unplanned). 
Regulation of walking during turning: Data were split according to turning strategies (step 
and spin turns) and turning conditions (preplanned and unplanned). For this analysis a 
minimum of three valid trials per individual and turning strategy/condition were required. 
Repeated measures ANOVA was used to evaluate the effects of medication (PD OFF and PD 
ON, two levels) and steps (straight walking and turning step 1-3; four levels) on step width. 
Two-way ANOVA was used to evaluate the difference between groups (PD ON and 
controls) and steps (straight walking and turning step 1-3) on step width. In the thesis, step 
width normalized to straight walking is presented. Positive values reveal wider turning steps 
compared to straight walking, whereas negative values reveal narrower turning steps 
compared to straight walking. 
The Greenhouse–Geisser correction was applied in the event of violations of sphericity, and 
Tukey’s HSD test in cases where significant interaction effects were found. Significance level 
was set at p ≤ 0.025 due to multiple analyses. Data are presented as mean and 95% 
confidence intervals (95% CI) or as median and interquartile range (IQR). 
3.8.2 Study III 
Training progression: Training activity of the two training groups was presented as the 
median value, quartiles and min-max for the training blocks (A, B and C). The analysis was 
performed in two steps. First, Wilcoxon signed-rank tests were used to compare the level of 
activity of all participants (n=10) between the blocks (i.e. A vs. B and B vs. C), with the 
significance level set at p ≤ 0.05. Thereafter, training progression was addressed for each 
training group by calculating the percentage differences in training activity between the 
training blocks (i.e. A vs. B and B vs. C). To denote evidence of training progression, an 
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increase of ≥20% in training activity between the blocks was required. This cut-off was 
applied using a pragmatic criterion, since, to date; no scientific criterion for training 
progression exists. 
3.8.3 Study IV 
Training effects: The differences between pre- and post-test performance in the training and 
control group were used for analysis. The Mini-BESTest, gait variables, FES-I, UPDRS-ADL 
and average steps per day were normally distributed, whereas the performance of the 
cognitive task and MFE-test revealed skewed distribution. Depending on the distribution of 
data, between group differences were analyzed using Independent t test or Mann-Whitney U 
test and presented as the mean (95% CI) or median difference (IQR), respectively. Effect size 
between the two independent groups was computed using Cohen’s d calculation.181 We used 
both an intention-to-treat (last value carried forward data imputation) and a per-protocol 
approach. However, since the analyses revealed similar results, and given the small dropout 
rate, only the results of the per-protocol analysis are reported. Significance level was set at p 
≤ 0.05. 
Dropout and missing data analysis: The Mann-Whitney U test and Fisher's exact test were 
used to assess whether differences in age, gender, UPDRS-motor score, H&Y score, Mini-
BESTest, comfortable walking velocity, UPDRS-ADL and FES-I were evident between  
subjects that dropped out compared with those who completed the study. Furthermore, due to 
the rather high proportion of missing data for physical activity (training group: 21%, control 
group: 27%), univariate logistic regression analysis was used to explore whether missing data 
were dependent on the observed values or missing at random.
182
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4 RESULTS 
This section summarizes the main results of the experimental (Study I) and clinical part 
(Study III and IV) of the thesis. Detailed results of each study are provided in the publications 
and manuscripts. 
4.1 EFFECTS OF DOPAMINERGIC MEDICATION ON TURNING WHILE 
WALKING  
Data concerning pre- and unplanned turning for PD OFF, PD ON and controls are provided 
in Table 8. Figure 8 provides an overview of the effects of medication on motor symptoms, 
straight walking, and pre- and unplanned turning. 
4.1.1 Balance control and gait 
Participants with PD perceived greater benefits of medication on mobility in the ON 
compared with OFF medication state as supported by significant higher median ratings of the 
visual analogue scale (PD OFF: 65 mm, IQR: 46─82, PD ON: 82 mm, IQR: 64─92, p = 
0.005). The median PIGD sub-score improved significantly after medication intake (PD OFF: 
4, IQR: 3─5, PD ON: 3, IQR: 2─4, p = 0.005), as well as the mean straight walking velocity 
(PD OFF: 1.17 m/s, CI: 1.09─1.25, PD ON: 1.24 m/s, CI: 1.17─1.30, p = 0.006) owing to the 
increase in step length (PD OFF: 0.60 m, CI: 0.56─0.64, PD ON: 0.63 m, CI: 0.59─0.66, p = 
0.008). 
 
Table 8. Preplanned and unplanned turning in PD OFF and ON and controls. 
 Preplanned turns  Unplanned turns 
 PD OFF PD ON CON  PD OFF PD ON CON 
Step turns (%) 48 
(39─57) 
50 
(41─59) 
47 
(39─54) 
 47  
(40─54) 
54 
(47─61) 
48 
(51─55) 
Body rotation  
(°)‡ 
77 
(68─86) 
80 
(72─88) 
99 
(92─105) 
 100 
(94─107) 
103 
(97─109) 
113 
(108─118) 
Turning distance 
(m)†‡ 
1.47 
(1.37─1.57) 
1.55 
(1.46─1.63) 
1.82 
(1.74─1.89) 
 1.39 
(1.29─1.49) 
1.46 
(1.36─1.55) 
1.74 
(1.67─1.82) 
Turning velocity 
(m/s) 
0.46 
(0.40─0.52) 
0.47 
(0.43─0.50) 
0.45 
(0.40─0.49) 
 0.18 
(0.16─0.20) 
0.19 
(0.17─0.22) 
0.22 
(0.20─0.25) 
Data represent mean values (95% confidence interval). Abbreviations: PD = Parkinson’s disease; CON = control 
† Significant medication effect (PD OFF vs. PD ON)  
‡ Significant group effect (PD ON vs. CON) 
 
4.1.2 Turning strategy and performance 
Independent of medication state (OFF and ON), for group (PD ON and controls) or type of 
turn performed (pre- and unplanned), the results revealed a nearly 50:50 distribution between 
the step and spin turns (Table 8). Medication significantly increased turning distance by 5% 
for pre- and unplanned turns (p = 0.003), whereas no significant effects on body rotation or 
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mean turning velocity (p > 0.025) were evident. No interaction effects were found between 
medication state and turning condition for any of the turning variables. These findings 
together with similar effects sizes for pre- and unplanned turns (Figure 8) suggest that the 
responsiveness to medication was similar for pre- and unplanned turns. 
During pre- and unplanned turns, PD ON turned a significantly shorter distance (17-19%) and 
obtained significantly lower body rotation at the third turning step (10-24%), compared with 
controls (group; p < 0.001). Once again, no interaction effects occurred (i.e. group × turning 
condition), suggesting that the differences between PD ON and controls were independent of 
the type of turn performed (i.e. pre- or unplanned turns). 
 
 
Figure 8. Effects of dopaminergic medication on balance control, gait and pre- and unplanned 
turns. Effect size (within groups: OFF vs. ON) was computed using Cohen's d. A value of 0.2, 0.5 
and 0.8 were considered small, moderate and large effects, respectively. Abbreviations: VAS = Visual 
analogue scale; PIGD = Postural Instability and Gait Difficulty. 
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Figure 9. Step width during pre- and unplanned turning while using A) step and B) spin turns. 
Mean step width (meter) normalized to straight walking (i.e. the absolute difference between straight 
walking and turning) for three turning steps for PD-OFF, PD-ON and controls. Error bars represent 
95% confidence interval. *p ≤ 0.01. 
 
4.1.3 Regulation of walking during step and spin turns 
There were significant main effects of medication on step width for the unplanned condition 
using step turns (p < 0.001) and for the pre- and unplanned condition using spin turns (p < 
0.017) (Figure 9a-b). These results reveal that subjects with PD turned, overall, with wider 
steps during ON medication compared with the OFF state. Concerning the preplanned 
condition using step turns, no effect of medication on step width was found (p > 0.025). 
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Furthermore, independent of the medication state, subjects with PD showed similar 
regulation of step width during turning, i.e. similar adjustments occurred compared with 
straight walking (medication × step: p > 0.025). Although both PD and controls demonstrated 
an alternation of step width while turning, i.e. wide - narrow - wide base of support for step 
turns and narrow - wide - narrow base of support for spin turns, this pattern was different in 
PD ON compared with controls (Figure 9a-b). In particular, there were no differences 
between the narrow steps and straight walking for PD ON (p > 0.025), while, overall, 
controls turned with wider steps compared with straight walking. 
4.2 TRAINING PROGRESSION THROUGHOUT 10-WEEKS OF BALANCE 
EXERCISES 
Training activity between Block A and B remained unchanged with regard to number of steps 
(median 860, IQR: 556─1316 vs. median 916, IQR: 712─1195, p = 0.799) and minutes spent 
walking >1.0m/s (median 19, IQR: 10─25 vs. median 19, IQR: 12─25, p = 0.333). In 
contrast, the comparison between Block B and C showed significant increases with regard to 
number of steps (C: median 1222, IQR: 882─1761, p = 0.005) and minutes spent walking 
>1m/s (C: median 26, IQR: 15-32, p = 0.005). Furthermore, by applying the criteria for 
progression (i.e. ≥20%) for each training group, similar results were found, i.e. a high level of 
progression occurred for both activity outcomes between Block B and C (Figure 10a-b). 
 
 
Figure 10. Training activity throughout the 10-week intervention. A) Volume and B) Intensity of 
dynamic exercises for training group I and II illustrated with boxplots for Block A (week 1-2), Block 
B (week 3-6) and Block C (week 7-10). The box plots represent median, quartiles and min-max.
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Figure 11. Effects of balance training on balance performance, gait and activities of everyday 
living. Effect size (between group: training vs. control) was computed using Cohen's d. A value of 
0.2, 0.5 and 0.8 are considered small, moderate and large effects, respectively. Abbreviations: Mini-
BESTest = Mini Balance Evaluation Systems Test; MFE = Modified figure of eight; UPDRS-ADL = 
Unified Parkinson’s Disease Rating Scale; FES-I = Falls Efficacy Scale–International. 
 
4.3 EFFECTS OF BALANCE TRAINING 
The differences between pre- and post-assessment for all outcome variables in the training 
and control group are shown in Table 9, and effect sizes for the outcome variables are 
reported in Figure 11. 
4.3.1 Balance control and gait 
The results revealed a large improvement in the Mini-BESTest (p < 0.001) in the training 
group compared with the control group, whereas no effect was found for MFE (p > 0.05). 
Moderate improvements were also found for gait velocity (p = 0.018) and step length during 
ST gait (p = 0.015) but not for cadence (p > 0.05) in the training group compared with the 
control group. Contrasting ST gait, no group differences were found for any gait parameters 
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during DT (p > 0.05). However, an effect was found for the cognitive task performance while 
walking (p = 0.006), representing a 9% improvement in the training group. There were no 
differences between groups for the performance of the cognitive task while seated (p > 0.05). 
4.3.2 Activities of everyday living 
A moderate training effect was found for the average number of steps per day (p = 0.033), 
representing a 6% increase in activity in the training group (+282 steps/day, CI: -206─768) 
and a 12% decline in activity in the control group (-548 steps/day, CI: -1164─68). However, 
as indicated by the 95% CI´s, none of these within-group differences were significant. 
Furthermore, a moderate improvement in UPDRS-ADL (p = 0.001) was found in the training 
group compared with the control group, with no training effect evident for FES-I (p > 0.05). 
4.3.3 Additional results 
4.3.3.1 Training compliance and adverse events 
The average attendance rate for the training-group was 90% (min-max: 66-100%). A total of 
13 adverse events (all were falls during training) out of a total of 1380 training sessions were 
reported, resulting in an incidence rate of 0.9%. None of the fall events caused injury or pain 
that interfered with the participants’ ability to proceed with the balance training or daily 
activities. 
4.3.3.2 Training and leisure activities in the control group 
During the intervention period, 59% of the subjects in the control group reported that they 
performed organized training weekly (mean frequency: two sessions per week). The most 
common training modalities were aerobic (n = 14), strength (n = 10) and balance training (n = 
4). Furthermore, 84% of the subjects in the control group performed leisure activities aimed 
at altering physical activity, with a mean frequency of 6 sessions/week and mean dosage of 4 
hours/week. The most common activity was brisk walks (n = 32). 
4.3.3.3 Dropout and missing data analysis 
As demonstrated in Table 9, age was the only variable that differed significantly between the 
subjects that dropped out (n = 10) and those who completed the study (n = 91). Accordingly, 
a significantly higher proportion of males dropped out of the study (78%) compared with 
those that completed the study (55%) (p < 0.001). Furthermore, no significant associations 
were found between baseline data (i.e. the variables included in Table 10) and incomplete 
physical activity data, thus indicating missing data at random.
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Table 9. Treatment effects for the training group and control group. 
 Training group (n = 47)  Control group (n = 44)   
  
n 
Mean 
diff 
95% CI 
 
 
n 
Mean 
diff 
95% CI 
 
 
P-value LB UB LB UB 
Balance control            
Mini-BESTest 47 3.0 2.3 3.7  44 0.9 0.0  1.7  <0.001 
Single-task gait 46     44      
Velocity (m/s)  0.10 0.04 0.14   0.00 -0.03   0.05  0.018 
Step length (m)  0.04 0.02 0.06   0.00 -0.01   0.02  0.015 
Cadence (steps/min)  3 1 5   0 -2   2  0.108 
Dual-task gait 45     42      
Velocity (m/s)  0.09 0.03 0.15   0.06 0.00   0.13  0.739 
Step length (m)  0.04 0.02 0.06   0.03 0.00   0.05  0.469 
Cadence (steps/min)  3 -2 7   3 -1   6  0.833 
Daily activity            
FES-I 47 -2.8 -5.1 -0.5  44 -2.3 -4.6   0.1  0.772 
Steps per day 37 282 -206 768  32 -548 -1164   68  0.033 
UPDRS-ADL 47 -1.7 -2.6 -0.8  44 0.4 -0.5   1.3  0.001 
 Training group (n = 47)  Control group (n = 44)   
  
n 
Median 
diff 
 
IQR 
  
n 
Median 
diff 
 
IQR 
  
P-value 
Cognitive task  45    42     
Single-task (% error)  0 19   0 17  0.634 
Dual-task (% error)  -9 18   2 15  0.006 
Balance control 44    39     
MFE Time (seconds)  -3 6   -2 5  0.506 
MFE oversteps (n)  -3 6   -2 7  0.393 
Treatment effects were calculated as the mean or median difference between pre- and post-test performances. Abbreviations: 
CI = confidence interval; LB = lower boundary, UB = upper boundary; n = numbers; Mini-BESTest = Mini Balance 
Evaluation Systems Test; UPDRS-ADL = Unified Parkinson’s Disease Rating Scale; FES-I = Falls Efficacy Scale–
International; IQR = interquartile range; MFE = Modified figure of eight. 
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Table 10. Dropout analysis. Baseline comparison between the participants that dropped out 
of the study and those completing the study. 
 Drop-outs (n = 9)  Completed the study (n = 91)   
 Mean (SD) Median (IQR)  Mean (SD) Median (IQR)  P-value 
Age (yrs) 71 (5) 72 (69─75)  73 (6) 72 (69─77)  0.412 
UPDRS-motor 40 (11) 40 (36─50)  36 (10) 36 (29─44)  0.2442 
UPDRS-ADL 15 (5) 13 (12─18)  13.4 (4.7) 13 (10─17)  0.427 
Mini-BESTest 18 (4) 19 (15─21)  19 (3.2) 19 (17─21)  0.687 
Walking velocity (m/s) 1.18 (0.13) 1.14 (1.09─1.24)  1.17 (0.19) 1.21 (1.00─1.30)  0.933 
FES-I 31 (10) 29 (27─34)  30 (10)  28 (23─35)  0.504 
 n/total %  n/total %   
Gender, male 7/9 78  50/91 55  <0.001 
H&Y, 3 4/7 57  52/91 57  1.000 
Abbreviations: n = numbers; UPDRS = Unified Parkinson’s Disease Rating Scale; ADL = Activities of daily living; Mini-
BESTest = Mini Balance Evaluation Systems Test; FES-I = Falls Efficacy Scale–International; H&Y = Hoehn and Yahr; SD = 
Standard deviation; IQR = interquartile range.  
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5 DISCUSSION 
5.1 MAIN FINDINGS 
This thesis intended to expand the current body of knowledge with regard to the effects of 
dopaminergic medication and exercise on balance control and activities of everyday living in 
older adults with mild to moderate PD.  
Experimental part (Study I): The results revealed that dopaminergic medication increased 
turning distance in individuals with PD but did not result in more efficient turns with regard 
to the rotation of the body for pre- and unplanned walking turns. Compared with the 
performance in the healthy control group, dopaminergic medication did not normalize turning 
performance. These findings suggest that problem with alternating step width during turning 
is a critical feature in PD which could be important to address in the rehabilitation of 
individuals with PD.  
Clinical part (Study II, III and IV): In Study II, a 10-week of balance training framework 
emphasizing specific and highly-challenging aspects of balance control, including DT, was 
developed through workshops and pilot testing. Findings of the objective evaluation of 
training activity (Study III) revealed that training progression was possible in two 
independent training groups of older adults with PD throughout the 10-week program. Study 
IV showed that a 10-week highly-challenging balance exercise program improved balance 
and gait performance in older adults with mild to moderate PD, compared with usual care. 
Positive transfer effects to activities of everyday living were also revealed, indicating that 
appropriate training programs could promote physical activity and daily activities in PD.
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5.2 EFFECTS OF DOPAMINERGIC MEDICATION ON TURNING WHILE 
WALKING 
Numerous studies have demonstrated positive effects of dopaminergic medication on periodic 
gait (i.e. walking straight),
111,115,116,183,184
 with this study being the first to evaluate the effects 
of dopaminergic medication on pre- and unplanned turns while walking in individuals with 
PD. Therefore, the experimental part of this thesis expands the current knowledge regarding 
the effects of medication on different features of pre- and unplanned walking turns. 
The intention with the experimental part of this thesis was to capture realistic turning 
behavior by using a paradigm where the subjects were free to perform a step or spin turn 
without spatial restrictions. Irrespective of OFF or ON medication, subjects with PD 
demonstrated a nearly 50:50 distribution between step and spin turns for both pre- and 
unplanned turns. This was an unexpected finding since step turns are considered favorable for 
individuals with balance impairments (e.g. PD) as they are safer and considered 
biomechanically less demanding (i.e. wider BoS and less axial rotation).
76,148
 This finding is 
somewhat contrary to previous studies in healthy older adults that have reported spin turns to 
be most common during preplanned turns,
148
 whilst step turns have showed to be preferred 
when performing more challenging turns, e.g. unplanned turns 
74
 or 90° preplanned turns 
during fast walking.
148
 Instead, the overall mixed preference between step and spin turns 
found in the present study could represent a consistently flexible repertoire of movement 
strategies unaffected by mild to moderate PD or older age. 
Although the subjects with PD demonstrated significant effects of medication on balance and 
gait, medication only partially improved their turning performance. Specifically, 
dopaminergic medication increased turning distance but not the efficiency of the body 
rotation around the longitudinal axis. Although previous findings reporting similar effects of 
dopaminergic medication on the performance of in-place
62,123
 and walking turns in 
individuals with PD,
111
 the divergent medication effect found in the present study is novel. 
Indeed, while it is known that the ability to turn while walking involves an interaction 
between the forward progression of the body and the rotation of the body around the 
longitudinal axis.
185
 According to the present results, the forward progression component 
appeared to be more responsive to dopaminergic medication. This notion is also supported by 
similar effects of medication found for turning distance and straight walking, both of which 
relate to the progression of the body while walking. 
Similar to previous findings,
111,115,123
 dopaminergic medication did not normalize turning 
performance, compared with the healthy control group, and these turning impairments in PD 
were accompanied with problems alternating step width during turning. Although being able 
to alternate between narrow and wide steps, the narrow steps of individuals with PD were 
equal to their step width during straight walking, while, in contrast, controls generally turned 
with wider steps than during straight walking. In individuals with PD, narrow step width has 
been demonstrated during balance reactions
50,186
 and walking turns.
150
 Narrow step width in 
PD could reduce medio-lateral stability
50,186
 and the force production necessary to accelerate 
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the center of mass towards the turn direction.
150
 Hence, it is likely that the narrower step 
width not only compromises turning performance in PD, but may also lead to instability and 
falls. This finding highlights the importance of targeting step width in individuals with PD 
during rehabilitation, e.g. by using reactive or proactive step training.
186,187
 
Furthermore, the similar effect of medication on pre- and unplanned turns was an unexpected 
finding. Lower effects of medication on unplanned turns were expected since this turn 
requires rapid identification of a cue and quick modification of the walking pattern
150,188
 as 
well as stresses impaired executive functioning in PD (e.g. planning, and selection of 
movements).
72
 This assumption was based on the combination of challenging features of 
unplanned turns together with findings of limited effects of dopaminergic medication on 
executive functions
189,190
 and the ability to shift between tasks in PD.
56
 Unplanned turns on 
the other hand, were triggered by a light signal, which have been reported to facilitate 
movements in individuals with PD.
191,192
 Accordingly, it is possible that the visual cue 
enhanced turning performance during unplanned turns; thus compensating for increased task 
complexity. 
5.3 TRAINING EFFECTS ON IMPAIRMENTS AND ACTIVITY LIMITIATIONS 
The clinical part of this thesis served to investigate the short-term effects of a 10-week 
training program of highly-challenging balance exercises, including DT, in older adults with 
PD. This study adds novelty to the existing body of research by demonstrating the prospects 
of applying DT to balance training and its effects across the spectrum of balance-related 
impairments in individuals with PD. 
The positive effects on balance control and gait in the training group are consistent with the 
results from recent meta-analyses of exercise interventions in PD.
126,193
 Furthermore, the 3-
point improvement in the training group on the Mini-BESTest is similar to the effects found 
in previous studies that have used this instrument to evaluate various exercise interventions 
on balance impairments in individuals with PD.
140,194,195
 The training group also had a Mini-
BESTest score of 22 points at post-assessment, which exceed the cut-off score (<19) that is 
associated with an increased risk of prospective falls in individuals with PD.
196
 Enhanced 
balance control in the training group was also linked to improved gait velocity (0.10 m/s) and 
step length (0.04 m) during ST walking. These findings could have important implications 
since gait velocity is a vital indicator of health.
197
 In fact, an increase of 0.10 m/s has been 
associated with decreased risk of mortality in older adults.
198
 
We found further positive effects in the training group for level of physical activity and 
activities of everyday living, thus, emphasizing the notion that specific improvements in 
balance control could transfer into activities of everyday living. A few previous studies have 
demonstrated positive effects of balance training on objectively measured physical 
activity
199,200
 and self-reported activities of daily living in individuals with PD.
194,201
 
Accordingly, the present study suggests that the promotion of activities in everyday living 
occurred in parallel to the improvement in balance control. Yet, these training effects were 
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rather small and should be cautiously interpreted. However, when dealing with a progressive 
disorder such as PD, such effects could be important in maintaining independency in daily 
activities, level of physical activity as well as promoting health.
105
 No training effect on 
concerns about falling was found, and the uncertainty remains on how the experience of 
highly-challenging balance exercises influences patients’ perception of their capacity. This 
unresolved question requires the application of a qualitative approach. 
This study was the first randomized controlled trial to evaluate the effects of an intervention 
that included DT exercises in individuals with PD. The results revealed that the training 
group improved their performance of the cognitive task during walking, compared with the 
control group, whilst no differences between the groups were found for DT gait. This is a 
contradictory finding compared to previous pilot studies in PD that have demonstrated 
improved DT gait performance following DT exercise but not for the secondary task.
129,132,133
 
The cognitive task used in the present study was a reciting task (i.e. reciting every second 
letter in the Swedish alphabet) which could be considered a task related to working memory, 
i.e. the ability to temporarily process, store and manipulate information in conscious 
awareness).
7
 As most of the DT exercises in the training program involved similar cognitive 
tasks (e.g. counting, remembering items/numbers), it is likely that the effects derived from the 
specificity of training. Furthermore, several plausible explanations exist while considering the 
underlying mechanisms for this DT improvement in the training group. First of all, improved 
ST performance might indirectly have improved DT performance by a more automatic 
control of the primary task (i.e. gait); thus, resulting in less overlap between the two tasks.
45
 
This view is supported by the large training effects found for ST performance in the training 
group. Alternatively, the positive effects found could be a consequence of improved 
efficiency of integrating the primary and secondary task.
45
 Although the field of DT training 
for individuals with PD is nascent,
45
 our findings indicate that DT performance might be 
improved in this population.
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5.4 METHODOLIGICAL CONSIDERATIONS 
5.4.1 External validity 
One important aspect of external validity is whether the recruited sample is representative of 
the population being studied.
202
 The sample of community-dwelling older adults with mild to 
moderate PD included in this thesis derived from the BETA-PD project.
203
 As such, this 
sample was selected from the population based on their interest and appropriateness of 
participating in this intervention. 
Several aspects regarding the criteria for inclusion and how the sample was recruited require 
consideration. First of all, similar to international data,
14
 about 90% of the individuals with 
PD in Sweden, to date, is above 60 years of age and PD is approximately 1.2 times more 
common among males than females.
12
 Accordingly, our sample matches the age dominance 
of the PD population as well as the ratio between males and females. Secondly, an inclusion 
criterion was ‘signs’ of impaired balance control at baseline clinical assessment. Despite the 
arbitrary nature of this criterion (i.e. no exact cut-off was used), this approach was applied 
from an ecological validity standpoint; an attempt to simulate the real-word setting in which 
individuals were included that would typically be considered for physiotherapy in clinical 
practice. Furthermore, 70% of the participants were recruited by advertisement, a method that 
could have led to a convenient sample of individuals interested in training and improving 
their physical status in general. Consequently, the risk of this approach is the possibility of 
attracting a ‘too healthy’ sample from the population and thereby failing to recruit more frail 
individuals that would benefit most from this intervention. The background characteristics of 
this sample (Table 2) revealed a group of independent ambulators with a mean walking 
velocity (about 1.2 m/s) and physical activity level (about 5000 steps per day) that were 
comparable to normative values of healthy older adults.
204,205
 But on the other hand, data on 
fall-history revealed that about 50% in this sample had experience ≥2 falls the last year, 
which is in line with the increased fall-risk in this population.
206
 Furthermore, the range in 
walking velocity and physical activity level, 0.67─1.55 m/s and 149─14495 steps per day, 
respectively, suggests varied physical capacities within this sample; ranging from frail to 
highly functional individuals. In accordance with the heterogeneous features of PD,
207
 it is 
likely that the diversity in the present sample also exists in the population studied. However, 
emphasizing recruitment from the health care system (only 10% in this project) had probably 
been a useful strategy in order to better target individuals with a more frail disability profile. 
The balance training intervention was conducted in the context of a university hospital setting 
and supervised by physiotherapists experienced in managing individuals with PD. This 
environment is resourceful not only owing to the experience of the physiotherapists, but also 
with regard to the accessibility of equipment and facilities that could promote this type of 
intervention. Although there might be similarities between different contexts, the results of 
this study regarding the effects of balance training should mainly be generalized to this 
context. 
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5.4.2 Internal validity 
5.4.2.1 Assessment of balance control in relation to dopaminergic medication state 
For all types of assessments of individuals with PD, it is important to take into account the 
influence of dopaminergic medication, such as changes in medication dose over time and the 
potential fluctuation in responsiveness to medication during the day.
22,101
 To improve the 
reproducibility of the assessment, it was therefore important to standardize the time of the day 
when the assessment took place, as well as consider the time since last medication intake. 
In the experimental part of this thesis, the responsiveness to dopaminergic medication on 
walking turns was assessed by comparing OFF and ON performance.
110
 Although all subjects 
included in the present study were confirmed to be responders to dopaminergic medication by 
their neurologist, the level of responsiveness to medication at the time of testing was not an 
inclusion criterion, as in other studies.
115,123
 Instead the responsiveness to medication in the 
present study was supported by significant benefits on balance and gait and participants’ 
perceived benefits of medication. Another option could have been to use a stricter criterion 
for inclusion, such as including those demonstrating ≥20% improvements in the UPDRS-
motor score after medication intake.
114,115
 However, this approach would have excluded eight 
subjects (42%) in the present study. Although such a more stringent approach would likely 
have improved the validity of the OFF vs. ON comparison, it may have restricted the 
generalization of the results to the population of individuals with mild to moderate PD. 
In the randomized controlled trial, all assessments of balance control were conducted during 
the ON state in order to restrict the impact of medication fluctuations. The participants were 
also instructed to maintain a stable medication dosage throughout the intervention period. 
Notwithstanding the recommendation, some participants changed their medication dose 
during the intervention; however, no significant differences were found in the proportions 
between the groups that increased or decreased their dosage. 
5.4.2.2 Bias related to testing 
Repeated measures is a threat to internal validity since testing itself could influence the 
variable of interest.
202
 Repeated measures were used in both parts of this thesis; during the 
same day (OFF followed by ON) in the experimental part and before and after the 10-week 
intervention period in the clinical part. 
For the evaluation of the medication effect, this approach may have led to an overestimation 
due to a practice effect where subjects with PD performed better during ON medication as 
they had more experience in the turning task, or an underestimation of the effect due to 
fatigue induced by repeated testing. Similar factors could have influenced the results in the 
randomized controlled, i.e. learning effects from being tested before and fatigue related to 
prolonged testing (each test session lasted approximately 3 hours). To address the risk of 
fatigue in both the experimental and clinical part, breaks were included in the test sessions 
and the participants were allowed to sit down and rest during testing. In addition, practice 
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sessions were held prior to formal testing in order to familiarize participants to the specific 
features of the test condition (e.g. performing pre-/unplanned turns or walking on an 
electronic walkway mat). To reduce the risk of systematic bias arising from a fixed order of 
testing, the order of the turning conditions (pre- and unplanned turns) was randomized in the 
experimental part as well as the order of the clinical tests in the clinical part. 
In the clinical study, several co-workers served as both trainers of the balance training and 
assessors during data collection in this project. As most tests require knowledge about and 
experience in the particular test, the risk of inconsistent evaluations between raters cannot be 
ruled out. To minimize this risk, all assessors were registered physiotherapists that had taken 
part in written instructions and discussions concerning the standardization of instructions and 
scoring of the tests prior to assessment. To reach consensus, tests that were assumed to be 
‘bias prone’ were also discussed between the assessors. Furthermore, the assessors were not 
masked to group allocation at the post-test assessment, which could have led to a favorable 
evaluation of the participants in the training group. However, during the follow-up 
assessments, participants were never assessed by a test leader who had been involved in their 
training. Although this strategy does not eliminate such testing bias, it was thus a pragmatic 
solution put in place given the numerous logistical challenges that come with a randomized 
controlled trial. 
5.4.2.3 Balance training: predetermined exercises vs. a framework approach 
There are different approaches available to execute a training program within a randomized 
controlled trial. One could use a fixed scheme of predetermined exercises for the trainers to 
follow or as in the present intervention, rely on the principles of a framework and the clinical 
reasoning of trainers (e.g. regarding the adaptation of exercise to individual capacities). 
There are pros and cons with both approaches. Interventions with predetermined exercises 
commonly offer an exact recipe of what exercise to perform, which could be beneficial in 
terms of reproducibility but be less adaptive to individual capacities and learning profiles 
over time. On the other hand, the benefits of a ‘framework’ approach could be the prospect of 
adjusting the training to individual capacities and their achievements over time. In the present 
study, a framework based on four balance components and a structure for training 
progression was applied to address balance impairment in individuals with PD. Importantly, 
the content of training was adapted to the group and the level of difficulty of balance exercise 
was adapted to the individual. This strategy was applied since mild to moderate PD is a 
heterogeneous group
207
 and thus less likely to benefit from a ‘one-size-fits-all’ treatment 
strategy. Furthermore, this approach was also used given its prospect of facilitating training 
progression over time, thereby promoting motor learning.
139
 Using this strategy that 
somewhat mimic clinical practice; require continuous evaluation of the trainers in order to 
modify training. To achieve this, all trainers involved in this study were physiotherapists 
educated in the framework of this training intervention. The critique towards such a strategy 
typically highlights the unstandardized features and the risk of the intervention changing over 
time. Still, the results from Study III revealing a similar progressive pattern of training 
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activity in two independent training groups (i.e. different trainers and training facilities); thus, 
supporting the consistency of this intervention. 
5.4.2.4 Laboratory vs. free-living assessments 
Assessment of balance and gait mostly uses clinical and quantitative assessments in 
standardized controlled environments and the results are assumed to reflect the individual’s 
performance in the “real-word” setting. The present experimental procedure aimed to assess 
walking turns as it occurs during everyday living, i.e. approximately 90° of turning performed 
across three steps.
90
 In particular, two different type of turns were analyzed to address the 
predictable (i.e. preplanned) and unpredictable (i.e. unplanned) features of walking in daily 
living.
78,79
 Similarly, in the clinical part, training effects on balance and gait were assessed in 
a laboratory environment with an electronical walkway system and clinical tests. 
However, testing in controlled environments without the influence of fatigue and motor 
fluctuations, together with the subjects desire to perform optimally, may provide an 
overestimation of the actual performance. For example, recent studies using body worn 
sensors to monitor gait have showed a discrepancy between laboratory gait performance and 
walking in everyday living in older healthy adults.
208,209
 Similar, in individuals with PD, the 
ability to turn in a controlled environment do not reflect their performance in their home 
environment.
210
 Accordingly, laboratory assessments are believed to represent an individual’s 
best performance rather than their usual performance.
208
 Still, the positive effects of balance 
training on laboratory gait performance and free-living measures of physical activity are 
encouraging results that support the notion of a link between ‘best’ and ‘actual’ performance. 
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5.5 CLINICAL IMPLICATIONS 
 As turning impairments were unsolved with dopaminergic medication, it is important 
to address these features in the rehabilitation of individuals with PD. Specifically, the 
findings suggest that exercises targeting the medio-lateral stability through 
appropriate step width modulation should be emphasized. 
 
 Highly-challenging balance exercises for 10-weeks improve balance control and gait 
performance and reveal positive transfer effects on everyday activities in older adults 
with mild to moderate PD. 
 
 Cognitive-demanding exercise, by application of DT, is not only feasible and safe in 
individuals with mild to moderate PD, but is also an ecologically valid approach to 
target motor-cognitive interference through training conditions that resemble 
everyday living. 
 
 Based on a systems approach of balance control,3 this exercise program was designed 
to target disease-related balance impairments in PD by applying the motor learning 
principles of specificity, progressive overload and varied practice. This approach is 
endorsed since the design of interventions is underpinned and guided by a framework 
that conceptualizes, for example, balance-related impairments, whilst the 
measurement of patient-specific outcomes is aligned to both the framework and the 
aims of the intervention. 
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5.6 FUTURE RESEARCH 
 For diagnostic and evaluation purposes of PD, there is a great need of establishing 
ecologically valid assessments of the responsiveness of dopaminergic medication 
within the domains of body impairments and activity. The complexity of turning 
impairments in individuals with PD also requires further investigation, such as the 
impact of executive function deficits. 
 
 The positive short-term effects of this balance training program are encouraging, but 
long-term promotion of balance control and an active lifestyle is of most importance. 
As such, future studies should investigate the long-term effects of highly-challenging 
balance training in individuals with PD. 
 
 In the context of the heterogeneous features of mild to moderate PD,207 it is crucial to 
explore whether certain disease characteristics of PD might be related to the response 
to cognitively-demanding DT exercise. For instance, as motor learning in PD is 
highly dependent on cognitive status,
211
 individuals with cognitive decline may gain 
better effects from ST exercise. Similarly, individuals experiencing frequent episodes 
of freezing of gait could gain more from compensatory strategies (e.g. cueing).
45
 
However, these assumptions are not grounded in evidence and future studies are 
warranted in order to improve the management of balance related impairments in 
individuals with PD. 
 
 In order to better understand the effects of different exercise modalities, it is crucial to 
improve the description of the active components of these interventions. For example, 
exercise programs that included movement of CoM, narrowing the BoS, and 
minimizing upper limb support were defined as highly-challenging in a meta-analysis 
in individuals with PD.
127
 One could argue that such generic descriptions of balance 
exercise insufficiently distinguish between training programs. Therefore, it is 
suggested that future studies aim to develop standardized methods of describing the 
content of balance training. 
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6 CONCLUSION 
 Independent of performing preplanned or unplanned walking turns, dopaminergic 
medication appears to improve the distance traveled during turning, but not the 
efficiency of turning with regard to body rotation in older adults with mild to 
moderate PD. 
 
 Dopaminergic medication does not normalize turning performance, these findings 
suggest that problems with alternating step width during turning is a critical feature in 
PD which could be important to address in further rehabilitation programs. 
 
 Training progression was possible throughout the 10-week program in two 
independent training groups of older individuals with PD. Interestingly, progression 
mainly occurred after habituation to challenging dual-task exercises and this finding 
could be useful while designing future interventions. 
 
 Highly-challenging and progressive balance exercises for 10-weeks, including dual-
tasking, improved balance and gait performance in older adults with PD when 
compared to usual care. Positive transfer effects to activities of everyday living were 
also revealed, indicating that appropriate training programs could promote physical 
activity and daily activities in older adults with PD.
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